WO1997032525A1 - Apparatus for creating linear lesions by ablation - Google Patents
Apparatus for creating linear lesions by ablation Download PDFInfo
- Publication number
- WO1997032525A1 WO1997032525A1 PCT/US1996/017536 US9617536W WO9732525A1 WO 1997032525 A1 WO1997032525 A1 WO 1997032525A1 US 9617536 W US9617536 W US 9617536W WO 9732525 A1 WO9732525 A1 WO 9732525A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- electrodes
- loop
- covering
- tubular member
- fluid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/056—Transvascular endocardial electrode systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/06—Electrodes for high-frequency therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00238—Type of minimally invasive operation
- A61B2017/00243—Type of minimally invasive operation cardiac
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00005—Cooling or heating of the probe or tissue immediately surrounding the probe
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00005—Cooling or heating of the probe or tissue immediately surrounding the probe
- A61B2018/00011—Cooling or heating of the probe or tissue immediately surrounding the probe with fluids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00059—Material properties
- A61B2018/00065—Material properties porous
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00059—Material properties
- A61B2018/00071—Electrical conductivity
- A61B2018/00083—Electrical conductivity low, i.e. electrically insulating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00107—Coatings on the energy applicator
- A61B2018/00113—Coatings on the energy applicator with foam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00345—Vascular system
- A61B2018/00351—Heart
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
- A61B2018/00577—Ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00642—Sensing and controlling the application of energy with feedback, i.e. closed loop control
- A61B2018/00654—Sensing and controlling the application of energy with feedback, i.e. closed loop control with individual control of each of a plurality of energy emitting elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00791—Temperature
- A61B2018/00821—Temperature measured by a thermocouple
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B2018/1405—Electrodes having a specific shape
- A61B2018/1407—Loop
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B2018/1405—Electrodes having a specific shape
- A61B2018/1435—Spiral
- A61B2018/1437—Spiral whereby the windings of the spiral touch each other such as to create a continuous surface
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B2018/1467—Probes or electrodes therefor using more than two electrodes on a single probe
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B2018/1472—Probes or electrodes therefor for use with liquid electrolyte, e.g. virtual electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B2018/1475—Electrodes retractable in or deployable from a housing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2218/00—Details of surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2218/001—Details of surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body having means for irrigation and/or aspiration of substances to and/or from the surgical site
- A61B2218/002—Irrigation
Definitions
- the present invention relates generally to the field of apparatuses and methods for ablating living tissue.
- the present invention relates to the field of devices and methods for creating lesions within the heart.
- Atrial fibrillation is a condition in the heart in which abnormal electrical signals are generated in the endocardial tissue to cause irregular beating of the heart .
- One method used to treat atrial fibrillation involves creating several long (i.e. approximately 2-10 cm) lesions on the endocardium within the atria. These lesions are intended to stop the irregular beating of the heart by creating barriers between regions of the atria. These barriers halt the passage through the heart of the abnormal currents generated by the endocardium. This procedure is commonly referred to as the "maze procedure" because it creates a maze of lesions design to block the passage of abnormal currents through the heart .
- the ablation tip of the catheter can sometimes lift off of the surface of the endocardium as it is dragged across the endocardium, creating one or more breaks in the lesion. Such breaks minimize the success of the ablation procedure by leaving a path through which current may travel during atrial fibrillation episodes.
- Another type of existing RF linear lesion catheter has a plurality of spaced ring electrodes encircling the distal end of the catheter. Although ablation using such catheters has been successful, a large spacing (i.e. on the order of greater than 4 mm) must be provided between the ring electrodes to give the catheter adequate flexibility to move through the vessels and the heart. Unfortunately, however, leaving large spaces between the electrodes may prevent RF energy from being focussed at certain points along the catheter and may thereby produce regions in the linear lesion which are not sufficiently necrosed to prevent the passage of current during atrial fibrillation episodes. Additionally, blood may coagulate on the surface of the metal ring electrodes, which can prevent RF energy from reaching the endocardial tissue.
- Coagulum on the surface of the electrodes may present a safety hazard in that it may eventually fall off the electrode and into the patient's bloodstream, causing an embolic event.
- Procedures and devices for forming linear lesions within the atria are therefore desired which will block the passage of current through the heart during atrial fibrillation episodes, as with the surgical incision procedure, but which utilize the less-invasive technique of a percutaneous catheter.
- a linear lesion catheter having the flexibility and maneuverability of the electrode tipped catheter but which generates a continuous lesion on the endocardium.
- the present invention is a catheter device for creating linear lesions in endocardial tissue or other body tissue.
- the catheter includes an elongate member having an ablation section at which a number of spaced apart electrodes are carried.
- An infusion tube is also carried by the elongate member.
- the infusion tube has a plurality of tiny holes positioned near the electrodes.
- the ablation section of the apparatus is positioned adjacent to the body tissue which is to be ablated.
- RF energy is delivered to the electrodes while saline or other conductive fluid is simultaneously delivered through the infusion tube.
- the conductive fluid passes out of the openings in the infusion tube and contacts the electrodes.
- the fluid also flows into contact with the body tissue, thereby improving the coupling of the RF energy from the electrodes to the tissue and improving the efficiency of the ablation of the tissue.
- Utilizing a conductive liquid which is dispersed over the desired area as a mechanism for coupling RF energy to the tissue produces lesions having greater continuity (and thus fewer breaks through which current can pass during atrial fibrillation episodes) than lesions formed by prior art apparatus which rely solely on direct contact between the electrodes and the body tissue.
- the conductive liquid also cools the electrodes, decreasing the likelihood of thrombus formation on the electrodes and thus decreasing the chance of embolism.
- delivery of current to the tissue is further improved by surrounding the electrodes with foam material and by covering the foam with a substantially fluid impermeable covering having a number of tiny holes formed in it.
- Saline (or another conductive medium) flowing into the foam is uniformly dispersed within it, and then is focussed onto the body tissue as it passes through the holes in the covering.
- the foam is deformable, it conforms the covering to the surface of the body tissue when the ablation section is positioned in contact with body tissue. Further, as saline infuses into the foam, it slightly expands the covering against the tissue thereby providing positive pressure between the covering and the body tissue.
- Certain of the embodiments are further provided with baffle wires that mechanically leverage the ablation section against the body tissue which is to be ablated by pushing against opposing body tissue.
- the ablation section may be fixed or slidable on the baffle wire.
- FIG. 1 is a side elevation view of a first embodiment of a linear lesion catheter according to the present invention.
- Fig. 2 is a cross-section view of the main shaft of the linear lesion catheter of Fig. 1, taken along the plane designated 2-2 in Fig. 1.
- Fig. 3 is a cross-section view of the baffle wire of the linear lesion catheter of Fig. 1, taken along the plane designated 3-3 in Fig. 1.
- Fig. 4 is a cross-section view of the ablation section of the linear lesion catheter of Fig. 1, taken along the plane designated 4-4 in Fig. 1.
- Fig. 5 is a cross-section view of the ablation section of the linear lesion catheter of Fig. 1, taken along the plane designated 5-5 in Fig. 4.
- Figs. 6A through 6D are a series of side elevation views of the linear lesion catheter of Fig. 1 illustrating operation of the device.
- Fig. 7 is a side elevation view of a second embodiment of a linear lesion catheter according to the present invention.
- Fig. 8A is a cross-section view of a proximal portion of the tubing of the catheter of Fig. 7, taken along the plane designated 8A-8A in Fig. 7.
- Fig. 8B is a cross-section view of a proximal portion of the tubing of the catheter of Fig. 7, taken along the plane designated 8B-8B in Fig. 7.
- Fig. 8C is a cross-section view of the baffle wire of the catheter of Fig. 7, taken along the plane designated 8C-8C in Fig. 7.
- Fig. 9 is a cross-section view of the ablation section of the catheter of Fig. 7, taken along the plane designated 9-9 in Fig. 7.
- Fig. 10 is a cross-section view of the ablation section of the catheter of Fig. 7, taken along the plane designated 10-10 in Fig. 9.
- Figs. 11A through 11D are a series of side elevation views of the linear lesion catheter of Fig. 7 illustrating operation of the device.
- Figs. 12A through 12C show a catheter which is similar to the cathether of Fig. 7 but which utilizes and an alternative tubing configuration.
- Fig. 12A is a side view of the alternative catheter.
- Fig. 12B is a cross-section view of a distal portion of the alternative catheter taken along the plane designed 12B-12B in Fig. 12A.
- Fig. 12C is a cross-section view of a proximal portion of the alternative catheter taken along the plane designed 12C-12C in Fig. 12A.
- Fig. 12D is a cross-section view of the ablation section of the alternative catheter taken along the plane designed 12D-12D in Fig. 12A.
- Fig. 12E is a cross-section view of the ablation of Fig. 12D, taken along the plane designated 12E-12E in Fig. 12D.
- Fig. 13A is a side elevation view of a third embodiment of a linear lesion catheter according to the present invention.
- Fig. 13B is a cross-sectional side view of a distal section of the catheter of Fig. 13A.
- Fig. 13C is a side elevation view of a portion of the catheter of Fig. 13A illustrating the manner in which the catheter secures the ablation section against endocardial tissue.
- Fig. 14A is a side elevation view of a fourth embodiment of a linear lesion catheter according to the present invention.
- Fig. 14B is a cross-sectional side view of a distal section of the catheter of Fig. 14A.
- Fig. 14C is a side elevation view of a portion of the catheter of Fig. 14A illustrating the manner in which the catheter secures the ablation section against endocardial tissue.
- Fig. 15A is a cross-sectional side view of a fifth embodiment of a linear lesion catheter according to the present invention.
- Fig. 15B is a side plan view of an embodiment similar to the embodiment of Fig. 15A, in which each of the foam segments is provided with a separate covering.
- Fig. 16 is a cross-sectional side view of a sixth embodiment of a linear lesion catheter according to the present invention which is similar to the fifth embodiment but in which the foam support structure of the fifth embodiment has been replaced by inflatable support structures.
- Fig. 17 is a cross-sectional side view of a seventh embodiment of a linear lesion catheter according to the present invention which is similar to the fifth embodiment but in which the foam support structure and covering have been removed.
- the catheter 10 is comprised generally of a main shaft 12, a looped baffle wire 14 which extends through the main shaft 12 and which is extendable out of the distal end of the main shaft 12, and an ablation section 16 formed on the baffle wire 14.
- the ablation section 16 is positioned against the target tissue to be ablated and which delivers RF energy to the tissue to cause ablation.
- ablation elements may be substituted for the RF ablation elements described in this and the following embodiments.
- ultrasound ablation elements or other conventional ablation tips may be used in combination with some or all of the other features of the invention described herein without departing from the scope of the present invention.
- main shaft 12 is an elongate shaft having a pair of lumens 18a, 18b extending from its proximal to its distal end.
- Main shaft 12 is subsantially straight in this and the other embodiments described herein, it may alternatively have a curved profile at its distal end to facilitate contact between it and the target tissue to be ablated.
- Main shaft is preferably constructed of a thermoplastic polymer, polyamid ether, polyurethane or other material having similar properties.
- a stainless steel braid (not shown) is preferably embedded in the wall of the main shaft by means conventionally known in the art. The inclusion of the braid improves the torque characteristics of the main shaft 12 and thus makes the main shaft easier to maneuver through patient's vessels and heart.
- baffle wire 14 is an elongate length a metallic core wire 20 encased in thin shrink tubing 21 or other flexible tubing such as polyolefin, thermoplastic polymer, polyamid ether (nylon), silicone, or polyurethane.
- Metallic core wire 20 extends the length of the shaft and may be formed of, for example, stainless steel or shape memory metal such as Nitinol.
- the baffle wire 14 may alternatively be formed of a more rigid material such as conventional braid tubing, in which case the core wire 20 may be eliminated.
- Baffle wire 14 extends through each of the lumen 18a, 18b in the main shaft 12 and forms a loop 22 (Fig.
- Baffle wire 14 includes a first end 26 which extends from a port 28 in connector 13. A second end 32 of baffle wire 14 lies within tubing 34 which extends from proximal end 30 of the main shaft and which will be described in detail below.
- Ablation section 16 of the catheter 10 is shown in cross-section view in Figs. 4 and 5.
- ablation section 16 includes a small diameter (i.e., approximately 0.5 mm dia.) fluid infusion tube 36 which extends adjacently to a portion of baffle wire 14.
- Infusion tube 36 includes a sealed distal end 37 and it extends proximally through the main shaft 12 and the tubing 34.
- a plurality of spaced holes 38 extend along the portion of the infusion tube 36 which lies at the ablation section 16.
- a plurality of lead wires 39 extend adjacently to the infusion tube 36 and the baffle wire 14.
- each lead wire 39 has a distal end coiled around the infusion tube 36, baffle wire 14, and other lead wires 39 to form a coil electrode 40.
- the proximal portions of the lead wires 39 extend through the main shaft 12 and tubing 34 and are coupled to an electrical adapter as will be described below.
- the portions of the lead wires 39 which are disposed within the ablation section 16 are not insulated from one another, while the portions of the lead wires 39 which lie within the main shaft 12 and tubing 34 are preferably insulated from one another by shrink tubing or other means.
- Electrodes may alternatively be used in this and the other embodiments described herein.
- ring electrodes may be utilized, or spaced conductive strips or bands may be formed on the surface of the baffle wire, or wire braids or other conductive material may be helically wound around the baffle shaft.
- the electrodes may also be formed from conductive wires or ribbons, each of which is covered by an insulated coating.
- An example of such wires (in an uncoiled form) is designated 94a in Fig. 12D and is described in the description accompanying Fig. 12D.
- the wire 94a is an 0.005 " diameter wire which is provided with exposed electrode regions 96a that are stripped of insulative material.
- Such flattened wires or ribbons may be advantageous in that they produce RF energy electric field lines which are not concentrated at the edges of the ribbons, but are instead dispersed along the entire length of the ribbon.
- Deformable members, or foam support segments 42 surround the electrodes 40. These segments 42 are formed of open cell polyurethane, cotton-like material, open-cell sponge, hydrogels, or other foam ⁇ like materials or materials which are permeable by conductive fluids and which exhibit some compressibility.
- the deformable member need not be segmented but it has been found that RF energy is more effectively channeled to the cardiac tissue by providing the foam in segments rather than in a continuous piece.
- the support segments 42 are preferably foam tubes which during manufacture are slipped over the baffle wire 14 into position over the electrodes.
- foam sheets may be wrapped around the electrodes to form tubes around the electrodes, and the overlapping sides of each sheet glued together to maintain each sheet in a tubular configuration.
- the support segments 42 are enclosed within a covering 44 formed of heat shrink polyethylene, silicone, or other polymeric materials having a plurality of small holes 46 or perforations formed in it.
- the covering 44 is preferably held in place by heating ends 48 (Fig. 1) of the covering to cause the heat shrink material to melt onto the baffle wire 1 .
- Covering 44 may also be a dip coating formed on the foam surface.
- the foam 42 and covering 44 are performed by the foam 42 and covering 44 during use of the device.
- the ablation section 16 of the device is positioned in contact with the region of the endocardium which is to be ablated.
- the foam provides structural support for the covering and facilitates contact between the covering and endocardial surface by compensating for features on the endocardial surface which are not smooth.
- the foam support segments may be replaced by other mechanical means which give structure integrity to the covering 44.
- inflatable balloons may be positioned within the covering and inflated to push the covering outwardly against the endocardial surface.
- the covering may be positioned over plastic or metallic spring structures.
- RF energy is delivered to the endocardium by a conductive path through the saline which flows through the foam and out of the covering onto the endocardium.
- the foam 42 helps the saline to flow evenly through and out of the covering and therefore facilitates transmission of RF energy to the endocardium.
- the plurality of tiny holes 46 formed in the covering 44 serve as the conduit through which saline passes from the foam to the endocardium.
- the fluid flow through the holes focuses the RF energy onto the tissue.
- the pattern in which the holes are arranged is selected to insure infusion of saline and delivery of RF energy to the underlying tissue even if the ablation section 16 should rotate during use.
- the distribution of holes formed in the covering should be limited to that which will create a continuous transmural linear lesion over the desired ablation surface. It has been found desirable to use four rows of 0.007" diameter holes spaced 1.0 mm apart over the length of the active region of the ablation section, to give approximately 40 such holes per centimeter over the active region.
- holes Six rows of holes (or 60 holes per centimeter) is also believed to give good results. It may also be desirable to arrange the holes so that they extend only along one side of the covering (i.e., the side which, during use, will be positioned against the target ablation site) in order to prevent RF energy from being lost into the blood pool. See, for example, holes 110a in Fig. 12D. It should be appreciated, however, that many hole sizes and patterns may be utilized without departing from the scope of the present invention.
- tubing 34 (which, as shown in Fig. 2, contains baffle wire 14, leads 39, and infusion tube 36 within it) extends through the main shaft 12 from the proximal end 24 of the main shaft, and it exits distal end 30 of main shaft via a port 50 in connector 13.
- Tubing 34 is slidably disposed within main shaft 12 and connector 13.
- Tubing 34 is joined at its proximal end to a second connector 52.
- Tubing 34 terminates at connector 52, and the infusion tube 36 and lead wires 39 which are within it (see Fig.
- infusion tube 36 is fluidly coupled with a fluid port 54 in connector 52 and such that lead wires 39 are electrically coupled to a female adapter 56.
- the portion of baffle wire 14 located at connector 52 does not extend into the fluid port 54 or the female adapter 56 but instead terminates at, and is fixed within, connector 52.
- Female adapter 56 is preferably configured to be coupled to a multi prong male adapter 58 (Fig. 6A) which is electrically coupled to a conventional RF generator (designated 60 in Fig. 6A) such as Model 8002 RF Generator which is available from Cardiac Pathways Corporation, Sunnyvale, California.
- Each lead wire 39 coupled to the female adapter preferably terminates in a socket which is separate from the other sockets in the female adapter and which is configured to mate with a corresponding prong of the male adapter.
- the linear lesion catheter is provided with six electrodes 40 (Fig. 2) , there will be six leads 39, each extending from one of the electrodes 40, and there will be at least six sockets in the female adapter which correspond to six prongs in the male adapter.
- tubing 34 and end 26 of baffle wire 14 are pulled in a proximal direction, as indicated by arrows in Fig. 6A, to withdraw the loop 22 inside distal end 24 of main shaft 12.
- Female adapter 56 is connected to a male adapter 58 which is coupled to a source 60 of RF energy.
- a conventional grounding patch or other grounding device is attached to the patient's body.
- main shaft 12 With the loop 22 inside main shaft 12, main shaft 12 is threaded through a patient's vessels and into the heart using conventional techniques. Once distal end 24 of main shaft 12 is positioned within the appropriate chamber of the heart, end 26 of baffle wire 14 and/or the tubing 34 is advanced distally to push the loop 22 out of distal end 24 of main shaft 12 (Fig. 6B) .
- the height, location and size of the loop 22 may be adjusted to position the ablation section 16 of the apparatus against the desired surface within the heart chamber and to maintain contact between the ablation surface of the catheter and the target surface within the heart chamber. These adjustments can be made by moving end 26 and/or tubing 34 distally or proximally as needed, and also by rotating the main shaft 12.
- tubing 34 may be moved distally to advance ablation section 16 and to thereby increase its curvature as shown in Fig. 6C, if such curvature will conform the ablation section 16 to the cardiac tissue T.
- loop 22 is preferably positioned within the heart such that ablation section 16 is leveraged against a chamber wall Wl by the action of the opposite side of the loop 22 against an opposing chamber wall W2 as in Fig. 6D.
- Pressing the ablation section 16 against the endocardium in this manner helps the ablation section to conform to the surface of the endocardium and thus helps ensure that sufficient contact is made between the ablation section and the endocardium.
- Good contact between the ablation section and the underlying tissue is essential to the creation of a continuous transmural lesion. Delivery of RF energy to the endocardial tissue is commenced once ablation section 16 is in contact with the desired region of the endocardial surface. RF energy from RF generator 60 is delivered to electrodes 40 via leads 39.
- conductive fluid such as saline S (Fig. 6A)
- saline S Fig. 6A
- infusion tube 36 It may also be desirable to begin to begin to apply positive fluid pressure even before RF ablation is commenced, in order to prevent blood accumulation in or on the covering.
- the saline passes through holes 38 in the infusion tube 36, then through the foam 42, and out of the covering 44 via holes 46.
- the saline moves from the holes 38 to the exterior of the covering, it creates a conductive path (for passage of the RF energy) between the electrodes and the endocardium (see arrows in Fig. 6D) .
- the RF energy travels along this conductive path from the electrodes, through the foam and the holes in the covering, and then into the tissue.
- the catheter 62 may be repositioned within the selected chamber of the heart and additional lesions formed.
- saline may alternatively or additionally be utilized in the present invention to cool the ablation electrodes.
- a second embodiment of a linear lesion catheter 62 is shown in Figs. 7 - 11B.
- the ablation section is positioned on a baffle loop at the distal end of the apparatus.
- the second embodiment differs from the first, however, in that in the second embodiment the ablation section is slidable over the baffle wire.
- Catheter 62 generally includes a main shaft 64, a baffle ribbon 66 which has one end fixed to the distal end of the main shaft 64 and another end extending through main shaft 64, and an ablation section 68 slidably received on the baffle ribbon 66.
- the ablation section 68 preferably has a length of approximately 2 - 10 cm and an outer diameter of approximately 3 - 5 mm.
- main shaft 64 includes a distal end 70 and a proximal end 72.
- the main shaft 64 is preferably a single lumen length of tubing constructed of a thermoplastic polymer, polyamid ether, polyurethane or other material having similar properties.
- the diameter of main shaft 64 is preferably approximately 9 - 11 French (approximately 3 - 4 mm) .
- a stainless steel braid (not shown) is preferably embedded in the wall of the main shaft by means conventionally known in the art. The inclusion of the braid improves the torque characteristics of the main shaft 64 and thus makes the main shaft easier to maneuver through a patient's vessels and heart.
- a Teflon ® lining (not shown), also conventional in the art, preferably lines the interior wall of the main shaft 64 to cover the wire braid.
- the braid is preferably absent from the first several centimeters at the distal tip 71 of the main shaft. This leaves the tip 71 sufficiently flexible to yield when advanced against obstacles within the vessels and heart.
- tubing 74 which is preferably made of a thick walled heat shrink tubing or thermoplastic polymer, is slidably received within main shaft 64 and is extendable from the distal end and proximal ends 70, 72 of the main shaft 64.
- a connector 76 is attached to the proximal end of tubing 74.
- Baffle ribbon 66 extends through a lumen 78 in the tubing 74 and is preferably covered with a Teflon ® coating. As shown, baffle ribbon 66 preferably has a substantially flat cross-section (i.e., rectangular or oblong) . This prevents the baffle ribbon 66 from rotating about its longitudinal axis during use.
- Baffle ribbon 66 has a distal end 80 which is secured to the distal end 70 of main shaft 64 as shown in Fig. 7.
- Baffle ribbon 66 extends through the ablation section 68 of the device as will be described below, enters the distal most portion of tubing 74 (see Fig. 8A) , and extends through the entire length of the tubing 74 (see Fig. 8B) . It further extends through connector 76 attached to the proximal most end of the tubing 74 and extends freely out of an opening in the proximal most end 80 of the connector (see Fig. 7) .
- an infusion tube 82 extends through the ablation section 68 and through the tubing 74.
- Infusion tube 82 includes a sealed distal end 84 and a proximal end 88 fluidly coupled with a fluid port 90 formed in connector 76.
- a plurality of spaced holes 92 extend through the portion of the infusion tube 82 positioned at the ablation section 68 of the device.
- a plurality of lead wires 94 (Figs. 8A, 8B and 10) , which are preferably formed of copper, extend through ablation section 68 and further extend through tubing 74, adjacent to the infusion tube 82. As can be seen in Fig.
- each lead wire 94 has a distal end which pokes through the shrink tubing 98 and is coiled to form a coil electrode 96 around the shrink tubing 98 and thus the infusion tube 82, the baffle ribbon 66, and the lead wires which are within it (see Fig. 10) .
- Each of the wires 94 passes through the shrink tubing 98 at a different point along the length of the ablation section 68 such that the electrode coils 96 are spaced from one another.
- the proximal portions of the lead wires 94 pass through the tubing 74 and are electrically coupled to a female adapter 100 as described with respect to the first embodiment.
- the portions of the lead wires 94 which are disposed within the ablation section 68 are not insulated from one another, while the portions of the lead wires 94 which lie within the tubing 74 are preferably insulated from one another by shrink tubing or other means.
- a stiffening wire 104 extends through a proximal portion of the tubing 74 to facilitate manipulation of the catheter 62 within a patient's vessels and heart.
- Stiffening tube 104 has a proximal end (not shown) which is secured to connector 76, and an unsecured distal end (not shown) located proximally of distal tip 71 of main shaft 64 (compare Figs.
- support segments 106 formed of open cell polyurethane or other foam material are positioned to surround the electrode coils 96.
- the foam need not be segmented but as described below it has been found that RF energy is more effectively channeled to the cardiac tissue by providing the foam in segments.
- the support segments 106 are preferably foam tubes which during manufacture are slipped over the baffle ribbon 66 and into position over the electrodes.
- the support segments 106 are enclosed within a covering 108 formed of heat shrink polyethylene or other polymeric material and preferably held in place by melting the distal and proximal ends of the covering onto the underlying structures.
- a plurality of tiny holes 110 are formed in the covering 108 and serve as the conduit through which saline passes from the foam to the endocardium.
- the pattern in which the holes are arranged is thus selected to insure infusion of saline and deliverance of RF energy to the underlying tissue even if the ablation section 68 should rotate during use. Because the holes focus the RF energy onto the tissue, it is preferable to limit the number of holes formed in the covering to that which will create a continuous transmural linear lesion.
- baffle ribbon 66 Prior to beginning the procedure, baffle ribbon 66 is pulled in a proximal direction to withdraw its distal portion as well as the ablation section 68 inside distal end 70 of main shaft 64. See Fig. 6A.
- Female adapter 100 is connected to a male adapter which is coupled to a source of RF energy as described above with respect to the first embodiment.
- the main shaft 64 is threaded via a patient's vessels (one of which is designated A in Fig. 11A) into the heart using conventional techniques.
- a patient's vessels one of which is designated A in Fig. 11A
- the proximal end of baffle ribbon 66 is advanced distally as shown in Fig. 11B. Because distal end 80 of baffle ribbon 66 is fixed to the main shaft 64, distal movement of the baffle ribbon causes it to form a loop 112 with itself. Additional distal movement of the baffle ribbon 66 increases the size of the loop 112 as shown in Fig. 11C.
- the position of the ablation section 68 along the baffle wire 66 may be adjusted by sliding tubing 74 in a proximal or distal direction (distal sliding is indicated in Fig. 11D) , to cause tubing 74 and thus inner shrink tube 98, to slide. Because the baffle ribbon 66 is not secured within the tubing 74 and 98, the tubing 74, 98 and the elements encased within it (i.e. the infusion tube 82 and the lead wires 94) slide over the baffle ribbon 66 while the baffle ribbon remains in place.
- RF energy from an RF generator is delivered to the coil electrodes 96 via leads 94 and is carried from the electrodes 96 to the endocardium by a conductive fluid, such as saline S (Fig. 11D) .
- a conductive fluid such as saline S (Fig. 11D) .
- the saline is directed into infusion tube 82 (Fig. 10) by fluid port 90. The saline passes through the holes 92 in the lumen 36, and then through the support segments 106, and it subsequently travels out of the covering 108 via holes 110.
- the saline moves from the holes 110 to the exterior of the covering, it carries the RF energy passed from the electrodes through the foam out of the covering and onto the endocardium.
- the user may reposition the ablation section 68 by sliding it proximally or distally over the baffle wire 66 (with or without first repositioning the baffle wire 600 within the chamber of the heart) in order to position the ablation section for formation of additional lesions.
- RF energy is delivered to the electrodes to form additional lesions or to increase the length of the previously formed lesion.
- Figs. 12A - 12C show an alternative catheter according to the present invention.
- This is embodiment is like the embodiment of Fig. 7 in that the ablation section 68a is slidable over a baffle wire, but it differs primarily with respect to the configuration of the tubing 74a which extends through the shaft 64.
- Figs. 12D and 12E are cross-section views of the ablation section 68a and illustrate the differences between the tubing 74a and the tubing 74 of the embodiment of Fig. 7.
- Fig. 12B shows the distal portion of the alternative tubing 74a.
- Tubing 74a is a five lumen tubing which obviates the need for the various other tubing (e.g., such as tubing 102 and 98) utilized in the embodiment shown in Figs. 8A and 8B. Elimination of tubing makes it easier to construct the catheter to have a small diameter. Thus, it may be desirable to utilize multi-lumen of this type in the first and second embodiments or in any embodiments of the device according to the present invention.
- Tubing 74a includes preferably four fluid lumen 82a and a baffle lumen 67 which extend throughout its proximal (Fig. 21C) and distal (Fig. 12B) sections. Lead wires 94a extend through the fluid lumen 82a. Each of four fluid ports 88a - 88d (Fig. 12A) is fluidly coupled to one of the fluid lumen 82a at the proximal end of the tubing 74a.
- Baffle ribbon 66a extends through a baffle ribbon lumen 67 in the tubing 74a.
- Baffle ribbon lumen 67 is preferably oblong shaped to prevent rotation of the baffle ribbon 66a within it.
- the proximal section tubing 74a includes the fluid lumen 82a and the baffle ribbon lumen 67 described above, and it also includes preferably two stiffening wire lumen 105.
- the seven lumen proximal portion of the tubing 74a and the five lumen distal portion are fused together by conventional means.
- stiffening wires are fused together by conventional means.
- stiffening wire lumen 105 extends through stiffening wire lumen 105 and thereby enhance the stiffness of the proximal portion of the catheter.
- Figs. 12D and 12E show the alternative ablation section 68a which utilizes the tubing 74a.
- Ablation section 68a is provided with foam segments or a foam layer, designated 106a, which is formed in an eccentric configuration such that it is thicker on one side of the ablation section 68a than it is on the other side.
- the side of the ablation section having the thick region of foam is positioned against the target tissue which is to be ablated.
- Foam 106a is enclosed within a fluid impermeable covering 108a which, as described with respect to previous embodiments, includes a plurality of tiny holes 110a. Holes 110a in the covering 108a may be formed only in the side of the covering at which the foam 106a is thickest. This helps to focus the RF energy onto the target tissue within the heart.
- holes 92a extend from the fluid lumen 82a through the tubing 74a to the foam layer 106a.
- the holes 92a are located at the side of the ablation section 68a at which the thickened foam region is located to permit the flow of conductive fluid from the fluid lumen 82a to the foam 106a and then through the holes 110a in the covering.
- the alternative ablation section 68a utilizes conductive wires 94a or flat conductive ribbons, each of which is covered by an insulated coating.
- the wires 94a which extend through the fluid lumen 82a, are preferably 0.005 " in diameter.
- Exposed electrode regions 96a (Fig. 12D) that are stripped of insulative material are spaced along the portion of the wires 94a that is located within the ablation section 68a.
- FIG. 13A and 13B A third embodiment of a linear lesion catheter 114 according to the present invention is shown in Figs. 13A and 13B.
- Catheter 114 differs primarily from those of the first and second embodiments in that a baffle wire loop protrudes laterally, rather than longitudinally, from the main shaft.
- This embodiment is generally comprised of a single lumen main shaft 116, an ablation section 118 positioned on the main shaft, and a baffle wire 120 which is slidably disposed within the main shaft 116.
- Main shaft 116 is preferably constructed of a thermoplastic polymer, polyamid ether, polyurethane or other material having similar properties.
- a stainless steel braid (not shown) is preferably embedded in the wall of the main shaft by means conventionally known in the art to improve the torque characteristics of the main shaft.
- a pair of openings 117a, 117b (Fig. 13B) are formed in the side of the main shaft. Each of the openings extends from the exterior of the main shaft to the interior.
- a platinum tip 122 is attached to the distal end of the main shaft 116 by an adhesive.
- a safety wire 124 may be soldered to the platinum tip 122 and fixed to an interior wall of the main shaft 116 to further insure that the tip 122 does not become detached from the main shaft during use.
- ablation section 118 includes a plurality of spaced coil electrodes 124, foam support segments 126, lead wires (not shown) and an infusion tube 128.
- Infusion tube 128 extends from an infusion port 130 (Fig. 13A) through the main shaft 116 and then passes through an opening 129 in the main shaft 116. Along the ablation section 118, infusion tube 128 extends along the exterior surface of the main shaft 116. As with the infusion tubes 36, 82 (see Figs. 4 and 10) of the first and second embodiments, a plurality of spaced holes (not shown) are preferably formed in the infusion tube to permit infusion of saline into and through the support segments 126.
- the lead wires extend from a female connector 129 positioned at the distal end of the catheter 114 and then pass through openings in the main shaft 116 (similar to opening 129 through which infusion tube 128 passes) at the ablation section 118.
- the coil electrodes 124 are preferably coiled around the infusion tube 128, the electrode leads (not shown) and the main shaft 116 as shown in Fig. 13B.
- a perforated covering 132 encloses the foam support segments 126 in the manner described with respect to the first and second embodiments.
- Baffle wire 120 is preferably formed of metallic stiffening wire, such as stainless steel, enclosed in thin walled shrink tube (not shown, but see Fig. 8C which shows a similar wire 66 and coating 78 configuration) .
- the baffle wire 120 may be formed of a flexible braid tube. Distal end 134 (Fig. 13B) of baffle wire 120 is fixed within the distal end of the main shaft 116, near the platinum tip 122. Baffle wire 120 passes out of the main shaft 116 via opening 117b and re-enters the main shaft via opening 117a to form an arc 135 adjacent the ablation section 118. Proximal end 136 of baffle wire 120 extends freely from a connector port 138 coupled to the proximal end of the main shaft 116 (Fig. 13A) .
- proximal end 136 of baffle wire 120 is pulled in a proximal direction to decrease the size of arc 135 and to thereby draw the arc 135 closer to the main shaft (see Fig. 13A) .
- the sheath catheter is withdrawn to expose the ablation section 118 and the arc 135.
- proximal end 136 of baffle wire 120 is advanced in a distal direction, as indicated by the arrow in Fig. 13B. Because distal end 134 of the baffle wire 120 is fixed within the main shaft, distal sliding of the baffle wire 120 causes an additional length of the baffle wire 120 to pass out of the main shaft via the hole 117a and thus increases the size of the arc. As the size of the arc increases, the arc pushes against adjacent tissue Tl and thus leverages the ablation section 118 against the portion T2 of the endocardium on which a lesion is to be formed. (See Fig. 13C) . Pressing the ablation section 118 against the endocardium in this manner helps the ablation section 118 to conform to the surface of the tissue T2 and thus helps to ensure that sufficient contact is made between the ablation section 118 and the endocardium.
- a fourth embodiment of a catheter 140 according to the present invention is shown in Fig. 14.
- the fourth embodiment is similar to the third in that a baffle wire loop protrudes from the main shaft. It differs from the fourth embodiment in that in includes an ablation section on the baffle wire.
- catheter 140 includes a main shaft 116a, and an ablation section 118a.
- Main shaft includes a platinum tip 122a similar to the platinum tip 122 of Fig. 13B, and it further includes a pair of holes 119a, 119b.
- At the proximal end of the main shaft 116 is a connector having an infusion port 130a, a second port 138a, and a female connector 129a.
- a baffle wire 120a extends through the main shaft 116a and includes a distal end 134a fixed to the distal end of the main shaft 116a.
- a free proximal end 136a extends from connector port 138a in the main shaft.
- a section of the baffle wire 120a extends through holes 119a, 119b in the main shaft 116a to form an arc 135a.
- ablation section 118a preferably includes a perforated covering 132a, foam support segments 126a, coil electrodes 124a, lead wires (not shown) and an infusion tube (not shown) .
- These elements are arranged on the arc 135a formed by baffle wire 120a in a manner which is preferably similar to the manner in which the covering 44, foam 42, electrodes 40, leads 39, baffle wire 20, and infusion tube 36 are arranged in the first embodiment .
- Reference is therefore made to Figs. 4 and 5 and the description thereof . Operation of the fourth embodiment of a linear lesion catheter 140 according to the present invention will next be described.
- baffle wire 120a is pulled in a proximal direction to draw the arc 135a closer to the main shaft (see Fig. 14A) .
- the catheter 140 may be inserted into a conventional sheath catheter (not shown) so as to compress the ablation section 118a and the arc 135a close to the main shaft 116a to prevent these structures from snagging on tissue within the vessels and the heart .
- the sheath catheter is withdrawn to expose the ablation section 118 after the distal portion of the catheter 112a has been fed through the patient's vessels and positioned in the desired chamber of the heart.
- baffle wire 120a is advanced in a distal direction, causing a portion of the baffle wire 120a to pass out of the main shaft via the hole 119a thereby increasing the size of the arc 135a.
- the arc and the main shaft push against opposing tissue surfaces Tl, T2 and thus leverage the ablation section 118a against the portion T2 of the endocardium on which a lesion is to be formed. (See Fig. 14C) .
- Pressing the ablation section 118a against the endocardium in this manner helps the ablation section 118a to conform to the surface of the endocardium and thus helps to ensure that sufficient contact is made between the ablation section 118 and the endocardium to create a continuous transmural lesion.
- a catheter 200 according to the present invention may be provided without a baffle wire as found in the previously described embodiments.
- Catheter 200 includes a main shaft 202 (preferably having a diameter of 7 French) and an ablation section 204 formed over the main shaft 202.
- a plurality of electrodes 206 are coiled around the main shaft 202, and (also at the ablation section 204) a plurality of spaced holes 208 are formed in the main shaft.
- a foam support structure 210 (which may be segmented as in prior embodiments) is formed around the main shaft and electrodes 206, and the support structure 210 is enclosed by a perforated covering 212.
- a core wire 214 extends through the central lumen of the main shaft 202. Wire 214 may alternatively be a pull wire of a type which may be used to steer the catheter 200 through a patient's vessels and heart. As shown in Fig.
- foam segments 210a may each be provided with separate coverings 212a, each of which is provided with a plurality of holes 211 along one side. It is desirable to provide four such 20 mm wide segments 210a, each spaced from the other segments 210a by approximately 1 mm.
- multiple lumen tubing having the configuration shown in Figs. 12B and 12C is utilized, with each of the fluid lumen (see lumen 82a in Figs. 12B and 12C) directing fluid from one of the fluid portions 88a - 88d to one of the foam segments 210a.
- the catheter 200 is inserted via vessels into a chamber of the heart, and positioned against the endocardial surface.
- Saline S is introduced into the central lumen of main shaft 202 (which in this embodiment serves as the infusion tube) and passes through the holes 208 into the foam structure 210.
- RF energy is delivered to the electrodes 206 via lead wires (not shown) as described with respect to previous embodiments .
- the outward pressure of the saline S within covering 212 causes the covering 212 to balloon out slightly and thereby improves contact between the ablation section 204 and the endocardium.
- Saline passes from the foam out of the ablation section via the perforations (not shown) in the covering 212 and in doing so creates an improved path of conductivity between the electrodes 206 and the endocardium.
- the foam support structure of the Fig. 15A embodiment and the previous embodiments may be replaced by other support structures which can press the covering of the ablation section against the endocardial wall during use.
- small inflatable balloons 215 (Fig. 16) may be positioned inside the covering 212 and provided with inflation tubes 216 which provide flow paths for the introduction of an inflation medium (such as air or fluid) into the balloons 215 during use.
- the foam and covering may be eliminated from the apparatus as shown in Fig. 17, in which case the conductive fluid or saline flows through openings 208 in the main shaft and is utilized primarily to cool the ablation electrodes 206, although it may also create a conductive path between the electrodes and target tissue.
- the electrodes 206 may be formed into coils, braids, or other configurations.
Abstract
An apparatus for ablating body tissue, and particularly for creating linear lesions within a chamber of a patient's heart, includes an elongate member having an ablation section. The ablation section includes an infusion tube and a plurality of spaced electrodes. The infusion tube and electrodes are covered by a fluid permeable foam material, and the foam material is covered by a fluid impermeable covering having a plurality of holes formed in it. During use, the ablation section is positioned against tissue to be ablated. Radiofrequency energy is delivered to the electrodes while saline or other conductive fluid is delivered to the infusion tube. The fluid exits the infusion tube at the ablation section, contacts the electrodes, and carries RF energy from the electrodes through the foam, through the holes in the covering and into contact with the body tissue to form a burn in the body tissue.
Description
APPARATUS FOR CREATING LINEAR LESIONS BY ABLATION
Field of the Invention
The present invention relates generally to the field of apparatuses and methods for ablating living tissue. In particular, the present invention relates to the field of devices and methods for creating lesions within the heart.
Background of the Invention
Atrial fibrillation is a condition in the heart in which abnormal electrical signals are generated in the endocardial tissue to cause irregular beating of the heart . One method used to treat atrial fibrillation involves creating several long (i.e. approximately 2-10 cm) lesions on the endocardium within the atria. These lesions are intended to stop the irregular beating of the heart by creating barriers between regions of the atria. These barriers halt the passage through the heart of the abnormal currents generated by the endocardium. This procedure is commonly referred to as the "maze procedure" because it creates a maze of lesions design to block the passage of abnormal currents through the heart .
Existing procedures for forming such linear lesions include the highly invasive technique of opening the patient's chest and heart and forming linear incisions inside the atria. Naturally, the highly invasive nature of this procedure makes it a particularly high risk to the patient and necessitates extraordinarily long recovery time. Other attempts have been made to form the linear lesions using ablation catheters fed into the heart via the patient's vessels (i.e., the arteries or veins) . For example, one such procedure involves
inserting into the atria a 7 French catheter having an ablation tip. Radio frequency (RF) energy is supplied to the tip as the tip is dragged across the endocardium, thereby burning linear lesions into the endocardium.
While often successful for forming linear lesions, the ablation tip of the catheter can sometimes lift off of the surface of the endocardium as it is dragged across the endocardium, creating one or more breaks in the lesion. Such breaks minimize the success of the ablation procedure by leaving a path through which current may travel during atrial fibrillation episodes.
Another type of existing RF linear lesion catheter has a plurality of spaced ring electrodes encircling the distal end of the catheter. Although ablation using such catheters has been successful, a large spacing (i.e. on the order of greater than 4 mm) must be provided between the ring electrodes to give the catheter adequate flexibility to move through the vessels and the heart. Unfortunately, however, leaving large spaces between the electrodes may prevent RF energy from being focussed at certain points along the catheter and may thereby produce regions in the linear lesion which are not sufficiently necrosed to prevent the passage of current during atrial fibrillation episodes. Additionally, blood may coagulate on the surface of the metal ring electrodes, which can prevent RF energy from reaching the endocardial tissue.
Coagulum on the surface of the electrodes may present a safety hazard in that it may eventually fall off the electrode and into the patient's bloodstream, causing an embolic event. Procedures and devices for forming linear lesions within the atria are therefore desired which
will block the passage of current through the heart during atrial fibrillation episodes, as with the surgical incision procedure, but which utilize the less-invasive technique of a percutaneous catheter. Further desirable is a linear lesion catheter having the flexibility and maneuverability of the electrode tipped catheter but which generates a continuous lesion on the endocardium.
It is further desirable to improve the continuity and thus the effectiveness of linear lesions formed using ablation catheters by providing means by which a linear lesion catheter may be held securely against endocardial tissue during ablation, and by which electrical energy may be focussed from the ablation electrodes onto the endocardium.
Summary of the Invention
The present invention is a catheter device for creating linear lesions in endocardial tissue or other body tissue. The catheter includes an elongate member having an ablation section at which a number of spaced apart electrodes are carried. An infusion tube is also carried by the elongate member. The infusion tube has a plurality of tiny holes positioned near the electrodes.
During use, the ablation section of the apparatus is positioned adjacent to the body tissue which is to be ablated. RF energy is delivered to the electrodes while saline or other conductive fluid is simultaneously delivered through the infusion tube.
The conductive fluid passes out of the openings in the infusion tube and contacts the electrodes. The fluid also flows into contact with the body tissue, thereby improving the coupling of the RF energy from the electrodes to the tissue and improving the efficiency of the ablation of the tissue.
Utilizing a conductive liquid which is dispersed over the desired area as a mechanism for coupling RF energy to the tissue produces lesions having greater continuity (and thus fewer breaks through which current can pass during atrial fibrillation episodes) than lesions formed by prior art apparatus which rely solely on direct contact between the electrodes and the body tissue. The conductive liquid also cools the electrodes, decreasing the likelihood of thrombus formation on the electrodes and thus decreasing the chance of embolism.
In preferred embodiments, delivery of current to the tissue is further improved by surrounding the electrodes with foam material and by covering the foam with a substantially fluid impermeable covering having a number of tiny holes formed in it. Saline (or another conductive medium) flowing into the foam is uniformly dispersed within it, and then is focussed onto the body tissue as it passes through the holes in the covering.
Because the foam is deformable, it conforms the covering to the surface of the body tissue when the ablation section is positioned in contact with body tissue. Further, as saline infuses into the foam, it slightly expands the covering against the tissue thereby providing positive pressure between the covering and the body tissue. Certain of the embodiments are further provided with baffle wires that mechanically leverage the ablation section against the body tissue which is to be ablated by pushing against opposing body tissue. In such embodiments, the ablation section may be fixed or slidable on the baffle wire.
Brief Descriptions of the Drawings
Fig. 1 is a side elevation view of a first embodiment of a linear lesion catheter according to the present invention.
Fig. 2 is a cross-section view of the main shaft of the linear lesion catheter of Fig. 1, taken along the plane designated 2-2 in Fig. 1.
Fig. 3 is a cross-section view of the baffle wire of the linear lesion catheter of Fig. 1, taken along the plane designated 3-3 in Fig. 1. Fig. 4 is a cross-section view of the ablation section of the linear lesion catheter of Fig. 1, taken along the plane designated 4-4 in Fig. 1.
Fig. 5 is a cross-section view of the ablation section of the linear lesion catheter of Fig. 1, taken along the plane designated 5-5 in Fig. 4.
Figs. 6A through 6D are a series of side elevation views of the linear lesion catheter of Fig. 1 illustrating operation of the device.
Fig. 7 is a side elevation view of a second embodiment of a linear lesion catheter according to the present invention.
Fig. 8A is a cross-section view of a proximal portion of the tubing of the catheter of Fig. 7, taken along the plane designated 8A-8A in Fig. 7. Fig. 8B is a cross-section view of a proximal portion of the tubing of the catheter of Fig. 7, taken along the plane designated 8B-8B in Fig. 7.
Fig. 8C is a cross-section view of the baffle wire of the catheter of Fig. 7, taken along the plane designated 8C-8C in Fig. 7.
Fig. 9 is a cross-section view of the ablation section of the catheter of Fig. 7, taken along the plane designated 9-9 in Fig. 7.
Fig. 10 is a cross-section view of the ablation section of the catheter of Fig. 7, taken along the plane designated 10-10 in Fig. 9.
Figs. 11A through 11D are a series of side elevation views of the linear lesion catheter of Fig. 7 illustrating operation of the device.
Figs. 12A through 12C show a catheter which is similar to the cathether of Fig. 7 but which utilizes and an alternative tubing configuration. Fig. 12A is a side view of the alternative catheter.
Fig. 12B is a cross-section view of a distal portion of the alternative catheter taken along the plane designed 12B-12B in Fig. 12A.
Fig. 12C is a cross-section view of a proximal portion of the alternative catheter taken along the plane designed 12C-12C in Fig. 12A.
Fig. 12D is a cross-section view of the ablation section of the alternative catheter taken along the plane designed 12D-12D in Fig. 12A.
Fig. 12E is a cross-section view of the ablation of Fig. 12D, taken along the plane designated 12E-12E in Fig. 12D. Fig. 13A is a side elevation view of a third embodiment of a linear lesion catheter according to the present invention.
Fig. 13B is a cross-sectional side view of a distal section of the catheter of Fig. 13A. Fig. 13C is a side elevation view of a portion of the catheter of Fig. 13A illustrating the manner in which the catheter secures the ablation section against endocardial tissue.
Fig. 14A is a side elevation view of a fourth embodiment of a linear lesion catheter according to the present invention.
Fig. 14B is a cross-sectional side view of a distal section of the catheter of Fig. 14A.
Fig. 14C is a side elevation view of a portion of the catheter of Fig. 14A illustrating the manner
in which the catheter secures the ablation section against endocardial tissue.
Fig. 15A is a cross-sectional side view of a fifth embodiment of a linear lesion catheter according to the present invention.
Fig. 15B is a side plan view of an embodiment similar to the embodiment of Fig. 15A, in which each of the foam segments is provided with a separate covering. Fig. 16 is a cross-sectional side view of a sixth embodiment of a linear lesion catheter according to the present invention which is similar to the fifth embodiment but in which the foam support structure of the fifth embodiment has been replaced by inflatable support structures.
Fig. 17 is a cross-sectional side view of a seventh embodiment of a linear lesion catheter according to the present invention which is similar to the fifth embodiment but in which the foam support structure and covering have been removed.
Detailed Description of Exemplary Embodiments A first embodiment of a linear lesion catheter
10 according to the present invention is shown in Fig. 1. The catheter 10 is comprised generally of a main shaft 12, a looped baffle wire 14 which extends through the main shaft 12 and which is extendable out of the distal end of the main shaft 12, and an ablation section 16 formed on the baffle wire 14. During use, the ablation section 16 is positioned against the target tissue to be ablated and which delivers RF energy to the tissue to cause ablation. It should be appreciated that other types of ablation elements may be substituted for the RF ablation
elements described in this and the following embodiments. For example, ultrasound ablation elements or other conventional ablation tips may be used in combination with some or all of the other features of the invention described herein without departing from the scope of the present invention.
Referring to Fig. 2, main shaft 12 is an elongate shaft having a pair of lumens 18a, 18b extending from its proximal to its distal end. Although the main shaft 12 is subsantially straight in this and the other embodiments described herein, it may alternatively have a curved profile at its distal end to facilitate contact between it and the target tissue to be ablated. Main shaft is preferably constructed of a thermoplastic polymer, polyamid ether, polyurethane or other material having similar properties. A stainless steel braid (not shown) is preferably embedded in the wall of the main shaft by means conventionally known in the art. The inclusion of the braid improves the torque characteristics of the main shaft 12 and thus makes the main shaft easier to maneuver through patient's vessels and heart. A connector 13 is attached to the proximal end of main shaft 12. Referring to Fig. 3, baffle wire 14 is an elongate length a metallic core wire 20 encased in thin shrink tubing 21 or other flexible tubing such as polyolefin, thermoplastic polymer, polyamid ether (nylon), silicone, or polyurethane. Metallic core wire 20 extends the length of the shaft and may be formed of, for example, stainless steel or shape memory metal such as Nitinol. The baffle wire 14 may alternatively be formed of a more rigid material such as conventional braid tubing, in which case the core wire 20 may be eliminated.
Baffle wire 14 extends through each of the lumen 18a, 18b in the main shaft 12 and forms a loop 22 (Fig. 1) adjacent to distal end 24 of the main shaft 12. Baffle wire 14 includes a first end 26 which extends from a port 28 in connector 13. A second end 32 of baffle wire 14 lies within tubing 34 which extends from proximal end 30 of the main shaft and which will be described in detail below.
Ablation section 16 of the catheter 10 is shown in cross-section view in Figs. 4 and 5. Referring to Fig. 5, ablation section 16 includes a small diameter (i.e., approximately 0.5 mm dia.) fluid infusion tube 36 which extends adjacently to a portion of baffle wire 14. Infusion tube 36 includes a sealed distal end 37 and it extends proximally through the main shaft 12 and the tubing 34. A plurality of spaced holes 38 extend along the portion of the infusion tube 36 which lies at the ablation section 16.
A plurality of lead wires 39 (Fig. 5) , which are preferably formed of copper, extend adjacently to the infusion tube 36 and the baffle wire 14. Referring to Fig. 4, each lead wire 39 has a distal end coiled around the infusion tube 36, baffle wire 14, and other lead wires 39 to form a coil electrode 40. The proximal portions of the lead wires 39 extend through the main shaft 12 and tubing 34 and are coupled to an electrical adapter as will be described below. The portions of the lead wires 39 which are disposed within the ablation section 16 are not insulated from one another, while the portions of the lead wires 39 which lie within the main shaft 12 and tubing 34 are preferably insulated from one another by shrink tubing or other means.
Other types of electrodes may alternatively be used in this and the other embodiments described herein. For example, ring electrodes may be
utilized, or spaced conductive strips or bands may be formed on the surface of the baffle wire, or wire braids or other conductive material may be helically wound around the baffle shaft. The electrodes may also be formed from conductive wires or ribbons, each of which is covered by an insulated coating. An example of such wires (in an uncoiled form) is designated 94a in Fig. 12D and is described in the description accompanying Fig. 12D. The wire 94a is an 0.005 " diameter wire which is provided with exposed electrode regions 96a that are stripped of insulative material. Such flattened wires or ribbons may be advantageous in that they produce RF energy electric field lines which are not concentrated at the edges of the ribbons, but are instead dispersed along the entire length of the ribbon.
Deformable members, or foam support segments 42 surround the electrodes 40. These segments 42 are formed of open cell polyurethane, cotton-like material, open-cell sponge, hydrogels, or other foam¬ like materials or materials which are permeable by conductive fluids and which exhibit some compressibility. The deformable member need not be segmented but it has been found that RF energy is more effectively channeled to the cardiac tissue by providing the foam in segments rather than in a continuous piece.
The support segments 42 are preferably foam tubes which during manufacture are slipped over the baffle wire 14 into position over the electrodes.
Alternatively, foam sheets may be wrapped around the electrodes to form tubes around the electrodes, and the overlapping sides of each sheet glued together to maintain each sheet in a tubular configuration. The support segments 42 are enclosed within a covering 44 formed of heat shrink polyethylene,
silicone, or other polymeric materials having a plurality of small holes 46 or perforations formed in it. The covering 44 is preferably held in place by heating ends 48 (Fig. 1) of the covering to cause the heat shrink material to melt onto the baffle wire 1 . Covering 44 may also be a dip coating formed on the foam surface.
A number of functions are performed by the foam 42 and covering 44 during use of the device. During use, the ablation section 16 of the device is positioned in contact with the region of the endocardium which is to be ablated. The foam provides structural support for the covering and facilitates contact between the covering and endocardial surface by compensating for features on the endocardial surface which are not smooth. It should therefore be appreciated that in this and the below described embodiments, the foam support segments may be replaced by other mechanical means which give structure integrity to the covering 44. For example, inflatable balloons may be positioned within the covering and inflated to push the covering outwardly against the endocardial surface. Alternatively, the covering may be positioned over plastic or metallic spring structures.
Further, as described in detail below, RF energy is delivered to the endocardium by a conductive path through the saline which flows through the foam and out of the covering onto the endocardium. The foam 42 helps the saline to flow evenly through and out of the covering and therefore facilitates transmission of RF energy to the endocardium.
The plurality of tiny holes 46 formed in the covering 44 serve as the conduit through which saline passes from the foam to the endocardium. The fluid flow through the holes focuses the RF energy onto the
tissue. The pattern in which the holes are arranged is selected to insure infusion of saline and delivery of RF energy to the underlying tissue even if the ablation section 16 should rotate during use. The distribution of holes formed in the covering should be limited to that which will create a continuous transmural linear lesion over the desired ablation surface. It has been found desirable to use four rows of 0.007" diameter holes spaced 1.0 mm apart over the length of the active region of the ablation section, to give approximately 40 such holes per centimeter over the active region. Six rows of holes (or 60 holes per centimeter) is also believed to give good results. It may also be desirable to arrange the holes so that they extend only along one side of the covering (i.e., the side which, during use, will be positioned against the target ablation site) in order to prevent RF energy from being lost into the blood pool. See, for example, holes 110a in Fig. 12D. It should be appreciated, however, that many hole sizes and patterns may be utilized without departing from the scope of the present invention.
The covering 44 helps to prevent blood from entering the ablation section, and the positive outward flow of saline from the covering reduces the likelihood of thrombus buildup at the ablation site. Referring to Fig. 1, tubing 34 (which, as shown in Fig. 2, contains baffle wire 14, leads 39, and infusion tube 36 within it) extends through the main shaft 12 from the proximal end 24 of the main shaft, and it exits distal end 30 of main shaft via a port 50 in connector 13. Tubing 34 is slidably disposed within main shaft 12 and connector 13. Tubing 34 is joined at its proximal end to a second connector 52. Tubing 34 terminates at
connector 52, and the infusion tube 36 and lead wires 39 which are within it (see Fig. 2) diverge from one another such that infusion tube 36 is fluidly coupled with a fluid port 54 in connector 52 and such that lead wires 39 are electrically coupled to a female adapter 56. The portion of baffle wire 14 located at connector 52 does not extend into the fluid port 54 or the female adapter 56 but instead terminates at, and is fixed within, connector 52. Female adapter 56 is preferably configured to be coupled to a multi prong male adapter 58 (Fig. 6A) which is electrically coupled to a conventional RF generator (designated 60 in Fig. 6A) such as Model 8002 RF Generator which is available from Cardiac Pathways Corporation, Sunnyvale, California. Each lead wire 39 coupled to the female adapter preferably terminates in a socket which is separate from the other sockets in the female adapter and which is configured to mate with a corresponding prong of the male adapter. Thus, for example, if the linear lesion catheter is provided with six electrodes 40 (Fig. 2) , there will be six leads 39, each extending from one of the electrodes 40, and there will be at least six sockets in the female adapter which correspond to six prongs in the male adapter.
Operation of the first embodiment 10 of a linear lesion ablation catheter 10 according to the present invention will next be described. Prior to beginning the procedure, tubing 34 and end 26 of baffle wire 14 are pulled in a proximal direction, as indicated by arrows in Fig. 6A, to withdraw the loop 22 inside distal end 24 of main shaft 12. Female adapter 56 is connected to a male adapter 58 which is coupled to a source 60 of RF energy. A conventional grounding
patch or other grounding device is attached to the patient's body.
With the loop 22 inside main shaft 12, main shaft 12 is threaded through a patient's vessels and into the heart using conventional techniques. Once distal end 24 of main shaft 12 is positioned within the appropriate chamber of the heart, end 26 of baffle wire 14 and/or the tubing 34 is advanced distally to push the loop 22 out of distal end 24 of main shaft 12 (Fig. 6B) . The height, location and size of the loop 22 may be adjusted to position the ablation section 16 of the apparatus against the desired surface within the heart chamber and to maintain contact between the ablation surface of the catheter and the target surface within the heart chamber. These adjustments can be made by moving end 26 and/or tubing 34 distally or proximally as needed, and also by rotating the main shaft 12.
For example, tubing 34 may be moved distally to advance ablation section 16 and to thereby increase its curvature as shown in Fig. 6C, if such curvature will conform the ablation section 16 to the cardiac tissue T.
Moreover, loop 22 is preferably positioned within the heart such that ablation section 16 is leveraged against a chamber wall Wl by the action of the opposite side of the loop 22 against an opposing chamber wall W2 as in Fig. 6D. Pressing the ablation section 16 against the endocardium in this manner helps the ablation section to conform to the surface of the endocardium and thus helps ensure that sufficient contact is made between the ablation section and the endocardium. Good contact between the ablation section and the underlying tissue is essential to the creation of a continuous transmural lesion.
Delivery of RF energy to the endocardial tissue is commenced once ablation section 16 is in contact with the desired region of the endocardial surface. RF energy from RF generator 60 is delivered to electrodes 40 via leads 39. At the same time, conductive fluid, such as saline S (Fig. 6A) , is directed into port 54 and through infusion tube 36. It may also be desirable to begin to begin to apply positive fluid pressure even before RF ablation is commenced, in order to prevent blood accumulation in or on the covering.
The saline passes through holes 38 in the infusion tube 36, then through the foam 42, and out of the covering 44 via holes 46. As the saline moves from the holes 38 to the exterior of the covering, it creates a conductive path (for passage of the RF energy) between the electrodes and the endocardium (see arrows in Fig. 6D) . The RF energy travels along this conductive path from the electrodes, through the foam and the holes in the covering, and then into the tissue. Once a lesion has been formed at the target spot, the catheter 62 may be repositioned within the selected chamber of the heart and additional lesions formed. Although it is preferred to utilize the conductive fluid or saline in a manner in which the conductive fluid creates a conductive path between the electrodes and the target tissue, saline may alternatively or additionally be utilized in the present invention to cool the ablation electrodes.
A second embodiment of a linear lesion catheter 62 is shown in Figs. 7 - 11B. Like the first embodiment, in the second embodiment the ablation section is positioned on a baffle loop at the distal end of the apparatus. The second embodiment differs
from the first, however, in that in the second embodiment the ablation section is slidable over the baffle wire. Thus, once the catheter has been inserted into a heart chamber and the loop has been formed to a desired size, the position of the ablation section on the loop may be adjusted to position the ablation section at the target ablation location.
Catheter 62 generally includes a main shaft 64, a baffle ribbon 66 which has one end fixed to the distal end of the main shaft 64 and another end extending through main shaft 64, and an ablation section 68 slidably received on the baffle ribbon 66. The ablation section 68 preferably has a length of approximately 2 - 10 cm and an outer diameter of approximately 3 - 5 mm.
Referring to Fig. 7, main shaft 64 includes a distal end 70 and a proximal end 72. The main shaft 64 is preferably a single lumen length of tubing constructed of a thermoplastic polymer, polyamid ether, polyurethane or other material having similar properties. The diameter of main shaft 64 is preferably approximately 9 - 11 French (approximately 3 - 4 mm) . A stainless steel braid (not shown) is preferably embedded in the wall of the main shaft by means conventionally known in the art. The inclusion of the braid improves the torque characteristics of the main shaft 64 and thus makes the main shaft easier to maneuver through a patient's vessels and heart. A Teflon® lining (not shown), also conventional in the art, preferably lines the interior wall of the main shaft 64 to cover the wire braid. To minimize tissue trauma as the main shaft 64 is fed through a patient's vessels and heart during use, the braid is preferably absent from the first several centimeters at the distal tip 71 of the
main shaft. This leaves the tip 71 sufficiently flexible to yield when advanced against obstacles within the vessels and heart.
Referring to Figs. 7, 8A and 8B, tubing 74, which is preferably made of a thick walled heat shrink tubing or thermoplastic polymer, is slidably received within main shaft 64 and is extendable from the distal end and proximal ends 70, 72 of the main shaft 64. A connector 76 is attached to the proximal end of tubing 74.
Baffle ribbon 66 extends through a lumen 78 in the tubing 74 and is preferably covered with a Teflon® coating. As shown, baffle ribbon 66 preferably has a substantially flat cross-section (i.e., rectangular or oblong) . This prevents the baffle ribbon 66 from rotating about its longitudinal axis during use.
Baffle ribbon 66 has a distal end 80 which is secured to the distal end 70 of main shaft 64 as shown in Fig. 7. Baffle ribbon 66 extends through the ablation section 68 of the device as will be described below, enters the distal most portion of tubing 74 (see Fig. 8A) , and extends through the entire length of the tubing 74 (see Fig. 8B) . It further extends through connector 76 attached to the proximal most end of the tubing 74 and extends freely out of an opening in the proximal most end 80 of the connector (see Fig. 7) .
Referring to Fig. 9, an infusion tube 82 extends through the ablation section 68 and through the tubing 74. Infusion tube 82 includes a sealed distal end 84 and a proximal end 88 fluidly coupled with a fluid port 90 formed in connector 76. A plurality of spaced holes 92 extend through the portion of the infusion tube 82 positioned at the ablation section 68 of the device.
A plurality of lead wires 94 (Figs. 8A, 8B and 10) , which are preferably formed of copper, extend through ablation section 68 and further extend through tubing 74, adjacent to the infusion tube 82. As can be seen in Fig. 10, at the ablation section 68 of the apparatus the lead wires 94, infusion tube 82, and the lumen that baffle ribbon 66 rides in are encased in thin walled polyethylene heat shrink tubing 98 (not visible in Fig. 9) . Each lead wire 94 has a distal end which pokes through the shrink tubing 98 and is coiled to form a coil electrode 96 around the shrink tubing 98 and thus the infusion tube 82, the baffle ribbon 66, and the lead wires which are within it (see Fig. 10) . Each of the wires 94 passes through the shrink tubing 98 at a different point along the length of the ablation section 68 such that the electrode coils 96 are spaced from one another. The proximal portions of the lead wires 94 pass through the tubing 74 and are electrically coupled to a female adapter 100 as described with respect to the first embodiment. The portions of the lead wires 94 which are disposed within the ablation section 68 are not insulated from one another, while the portions of the lead wires 94 which lie within the tubing 74 are preferably insulated from one another by shrink tubing or other means.
As can be seen in Figs. 8A and 8B, the portions of the infusion tube 82 and lead wires 94 which are disposed within the tubing 74 are bundled together using thin walled polyethylene heat shrink tubing 102, whereas the portion of the baffle ribbon 66 lying within the tubing 74 is preferably not bundled within the tubing 102. A stiffening wire 104 extends through a proximal portion of the tubing 74 to facilitate manipulation of the catheter 62 within a patient's vessels and heart. Stiffening tube 104 has
a proximal end (not shown) which is secured to connector 76, and an unsecured distal end (not shown) located proximally of distal tip 71 of main shaft 64 (compare Figs. 8A and 8B) . Referring again to Figs. 8A, 8B and 10, it can be seen that the same shrink tubing 98 which, at the ablation portion 68 (Fig. 10) of the device, encloses the leads 94, the lumen 78 within which the baffle ribbon 66 rides, and fluid lumen 82 also encloses tubing 102 (including infusion tube 82 and lead wires 94 which are within it) , the lumen 78 within which the baffle ribbon 66 rides, and the stiffening wire 104 which are enclosed within the tubing 74. Moreover, it should be understood that during manufacture the thick walled tubing 74 becomes melted onto the underlying tubing 98 and thus prevents sliding of the shrink tubing 98 within the tubing 74.
Referring to Figs. 9 and 10, support segments 106 formed of open cell polyurethane or other foam material are positioned to surround the electrode coils 96. The foam need not be segmented but as described below it has been found that RF energy is more effectively channeled to the cardiac tissue by providing the foam in segments. As described with respect to the first embodiment, the support segments 106 are preferably foam tubes which during manufacture are slipped over the baffle ribbon 66 and into position over the electrodes.
The support segments 106 are enclosed within a covering 108 formed of heat shrink polyethylene or other polymeric material and preferably held in place by melting the distal and proximal ends of the covering onto the underlying structures.
A plurality of tiny holes 110 are formed in the covering 108 and serve as the conduit through which saline passes from the foam to the endocardium. The
pattern in which the holes are arranged is thus selected to insure infusion of saline and deliverance of RF energy to the underlying tissue even if the ablation section 68 should rotate during use. Because the holes focus the RF energy onto the tissue, it is preferable to limit the number of holes formed in the covering to that which will create a continuous transmural linear lesion.
Operation of the preferred catheter 62 according to the present invention will next be described.
Prior to beginning the procedure, baffle ribbon 66 is pulled in a proximal direction to withdraw its distal portion as well as the ablation section 68 inside distal end 70 of main shaft 64. See Fig. 6A. Female adapter 100 is connected to a male adapter which is coupled to a source of RF energy as described above with respect to the first embodiment.
Once the ablation section 68 and the distal portion of the baffle ribbon 66 are inside main shaft 64, the main shaft 64 is threaded via a patient's vessels (one of which is designated A in Fig. 11A) into the heart using conventional techniques. Once distal end 70 of main shaft 64 is positioned within the appropriate chamber of the heart, the proximal end of baffle ribbon 66 is advanced distally as shown in Fig. 11B. Because distal end 80 of baffle ribbon 66 is fixed to the main shaft 64, distal movement of the baffle ribbon causes it to form a loop 112 with itself. Additional distal movement of the baffle ribbon 66 increases the size of the loop 112 as shown in Fig. 11C. Deployment of the baffle ribbon 66 continues until the loop 112 is of sufficient size that it fills the heart chamber (i.e., such that both ablation section 68 and the side of the loop 112 opposing the ablation section are in contact with opposition regions Tl and &2 of endocardial tissue) .
Next, the position of the ablation section 68 along the baffle wire 66 may be adjusted by sliding tubing 74 in a proximal or distal direction (distal sliding is indicated in Fig. 11D) , to cause tubing 74 and thus inner shrink tube 98, to slide. Because the baffle ribbon 66 is not secured within the tubing 74 and 98, the tubing 74, 98 and the elements encased within it (i.e. the infusion tube 82 and the lead wires 94) slide over the baffle ribbon 66 while the baffle ribbon remains in place.
As described with respect to the first embodiment, delivery of RF energy to the endocardial tissue is commenced once ablation section 68 has been positioned in contact with the desired region of the endocardial surface. RF energy from an RF generator is delivered to the coil electrodes 96 via leads 94 and is carried from the electrodes 96 to the endocardium by a conductive fluid, such as saline S (Fig. 11D) . As with the previous embodiment, the saline is directed into infusion tube 82 (Fig. 10) by fluid port 90. The saline passes through the holes 92 in the lumen 36, and then through the support segments 106, and it subsequently travels out of the covering 108 via holes 110. As the saline moves from the holes 110 to the exterior of the covering, it carries the RF energy passed from the electrodes through the foam out of the covering and onto the endocardium. Once a lesion has been formed at the desired spot, the user may reposition the ablation section 68 by sliding it proximally or distally over the baffle wire 66 (with or without first repositioning the baffle wire 600 within the chamber of the heart) in order to position the ablation section for formation of additional lesions. Once the ablation section is repositioned, RF energy is delivered to the electrodes to form additional
lesions or to increase the length of the previously formed lesion.
Figs. 12A - 12C show an alternative catheter according to the present invention. This is embodiment is like the embodiment of Fig. 7 in that the ablation section 68a is slidable over a baffle wire, but it differs primarily with respect to the configuration of the tubing 74a which extends through the shaft 64. Figs. 12D and 12E are cross-section views of the ablation section 68a and illustrate the differences between the tubing 74a and the tubing 74 of the embodiment of Fig. 7.
Fig. 12B shows the distal portion of the alternative tubing 74a. Tubing 74a is a five lumen tubing which obviates the need for the various other tubing (e.g., such as tubing 102 and 98) utilized in the embodiment shown in Figs. 8A and 8B. Elimination of tubing makes it easier to construct the catheter to have a small diameter. Thus, it may be desirable to utilize multi-lumen of this type in the first and second embodiments or in any embodiments of the device according to the present invention.
Tubing 74a includes preferably four fluid lumen 82a and a baffle lumen 67 which extend throughout its proximal (Fig. 21C) and distal (Fig. 12B) sections. Lead wires 94a extend through the fluid lumen 82a. Each of four fluid ports 88a - 88d (Fig. 12A) is fluidly coupled to one of the fluid lumen 82a at the proximal end of the tubing 74a.
Baffle ribbon 66a extends through a baffle ribbon lumen 67 in the tubing 74a. Baffle ribbon lumen 67 is preferably oblong shaped to prevent rotation of the baffle ribbon 66a within it. Referring to the proximal portion of tubing 74a shown in Fig. 12C, the proximal section tubing 74a
includes the fluid lumen 82a and the baffle ribbon lumen 67 described above, and it also includes preferably two stiffening wire lumen 105. Thus, there are five lumen extending through the distal portion (Fig. 12B) of the tubing 74a and there are seven lumen extending through the proximal portion (Fig. 12C) . The seven lumen proximal portion of the tubing 74a and the five lumen distal portion are fused together by conventional means. Referring again to Fig. 12C, stiffening wires
104a extend through stiffening wire lumen 105 and thereby enhance the stiffness of the proximal portion of the catheter.
Figs. 12D and 12E show the alternative ablation section 68a which utilizes the tubing 74a. Ablation section 68a is provided with foam segments or a foam layer, designated 106a, which is formed in an eccentric configuration such that it is thicker on one side of the ablation section 68a than it is on the other side. During use, the side of the ablation section having the thick region of foam is positioned against the target tissue which is to be ablated.
Foam 106a is enclosed within a fluid impermeable covering 108a which, as described with respect to previous embodiments, includes a plurality of tiny holes 110a. Holes 110a in the covering 108a may be formed only in the side of the covering at which the foam 106a is thickest. This helps to focus the RF energy onto the target tissue within the heart. At the ablation section, holes 92a extend from the fluid lumen 82a through the tubing 74a to the foam layer 106a. The holes 92a are located at the side of the ablation section 68a at which the thickened foam region is located to permit the flow of conductive fluid from the fluid lumen 82a to the
foam 106a and then through the holes 110a in the covering.
Rather than utilizing coil electrodes of the type described above, the alternative ablation section 68a utilizes conductive wires 94a or flat conductive ribbons, each of which is covered by an insulated coating. The wires 94a, which extend through the fluid lumen 82a, are preferably 0.005 " in diameter. Exposed electrode regions 96a (Fig. 12D) that are stripped of insulative material are spaced along the portion of the wires 94a that is located within the ablation section 68a.
Operation of the embodiment of Figs. 12A - 12E is similar to the operation of the embodiment of Fig. 7 and need not be repeated here.
A third embodiment of a linear lesion catheter 114 according to the present invention is shown in Figs. 13A and 13B. Catheter 114 differs primarily from those of the first and second embodiments in that a baffle wire loop protrudes laterally, rather than longitudinally, from the main shaft.
This embodiment is generally comprised of a single lumen main shaft 116, an ablation section 118 positioned on the main shaft, and a baffle wire 120 which is slidably disposed within the main shaft 116.
Main shaft 116 is preferably constructed of a thermoplastic polymer, polyamid ether, polyurethane or other material having similar properties. A stainless steel braid (not shown) is preferably embedded in the wall of the main shaft by means conventionally known in the art to improve the torque characteristics of the main shaft. A pair of openings 117a, 117b (Fig. 13B) are formed in the side of the main shaft. Each of the openings extends from the exterior of the main shaft to the interior.
A platinum tip 122 is attached to the distal end of the main shaft 116 by an adhesive. A safety wire 124 may be soldered to the platinum tip 122 and fixed to an interior wall of the main shaft 116 to further insure that the tip 122 does not become detached from the main shaft during use. During use the tip 122 serves as a radiopaque marker which fluoroscopically indicates the position of the distal end of the catheter. As with the previous embodiments, ablation section 118 includes a plurality of spaced coil electrodes 124, foam support segments 126, lead wires (not shown) and an infusion tube 128.
Infusion tube 128 extends from an infusion port 130 (Fig. 13A) through the main shaft 116 and then passes through an opening 129 in the main shaft 116. Along the ablation section 118, infusion tube 128 extends along the exterior surface of the main shaft 116. As with the infusion tubes 36, 82 (see Figs. 4 and 10) of the first and second embodiments, a plurality of spaced holes (not shown) are preferably formed in the infusion tube to permit infusion of saline into and through the support segments 126.
The lead wires (not shown) extend from a female connector 129 positioned at the distal end of the catheter 114 and then pass through openings in the main shaft 116 (similar to opening 129 through which infusion tube 128 passes) at the ablation section 118. The coil electrodes 124 are preferably coiled around the infusion tube 128, the electrode leads (not shown) and the main shaft 116 as shown in Fig. 13B. A perforated covering 132 encloses the foam support segments 126 in the manner described with respect to the first and second embodiments.
Baffle wire 120 is preferably formed of metallic stiffening wire, such as stainless steel, enclosed in thin walled shrink tube (not shown, but see Fig. 8C which shows a similar wire 66 and coating 78 configuration) . Alternatively, the baffle wire 120 may be formed of a flexible braid tube. Distal end 134 (Fig. 13B) of baffle wire 120 is fixed within the distal end of the main shaft 116, near the platinum tip 122. Baffle wire 120 passes out of the main shaft 116 via opening 117b and re-enters the main shaft via opening 117a to form an arc 135 adjacent the ablation section 118. Proximal end 136 of baffle wire 120 extends freely from a connector port 138 coupled to the proximal end of the main shaft 116 (Fig. 13A) .
Operation of the third embodiment of a linear lesion catheter 114 according to the present invention will next be described. To prepare the device for insertion into a patient's vessels, proximal end 136 of baffle wire 120 is pulled in a proximal direction to decrease the size of arc 135 and to thereby draw the arc 135 closer to the main shaft (see Fig. 13A) . To facilitate insertion of the catheter 114 into a vessel, it may also be desirable to insert the catheter 114 into a conventional sheath catheter (not shown) so as to compress the ablation section 118 and the arc 135 close to the main shaft and to thereby prevent these structures from snagging on tissue within the vessels and the heart. Once the distal portion of the catheter 112 reaches the desired chamber of the heart, the sheath catheter is withdrawn to expose the ablation section 118 and the arc 135.
Once the ablation section 118 is within the heart chamber and positioned adjacent a region of the endocardium which is to be ablated, proximal end 136
of baffle wire 120 is advanced in a distal direction, as indicated by the arrow in Fig. 13B. Because distal end 134 of the baffle wire 120 is fixed within the main shaft, distal sliding of the baffle wire 120 causes an additional length of the baffle wire 120 to pass out of the main shaft via the hole 117a and thus increases the size of the arc. As the size of the arc increases, the arc pushes against adjacent tissue Tl and thus leverages the ablation section 118 against the portion T2 of the endocardium on which a lesion is to be formed. (See Fig. 13C) . Pressing the ablation section 118 against the endocardium in this manner helps the ablation section 118 to conform to the surface of the tissue T2 and thus helps to ensure that sufficient contact is made between the ablation section 118 and the endocardium.
Next, delivery of saline and RF energy to the ablation section 118 is carried out as described with respect to the first and second embodiments to cause the lesion to be formed.
A fourth embodiment of a catheter 140 according to the present invention is shown in Fig. 14. The fourth embodiment is similar to the third in that a baffle wire loop protrudes from the main shaft. It differs from the fourth embodiment in that in includes an ablation section on the baffle wire.
As with the catheter 114 of the third embodiment (Fig. 13A) , catheter 140 includes a main shaft 116a, and an ablation section 118a. Main shaft includes a platinum tip 122a similar to the platinum tip 122 of Fig. 13B, and it further includes a pair of holes 119a, 119b. At the proximal end of the main shaft 116 is a connector having an infusion port 130a, a second port 138a, and a female connector 129a.
A baffle wire 120a extends through the main shaft 116a and includes a distal end 134a fixed to the distal end of the main shaft 116a. A free proximal end 136a extends from connector port 138a in the main shaft. A section of the baffle wire 120a extends through holes 119a, 119b in the main shaft 116a to form an arc 135a.
As with the above-described embodiments, ablation section 118a preferably includes a perforated covering 132a, foam support segments 126a, coil electrodes 124a, lead wires (not shown) and an infusion tube (not shown) . These elements are arranged on the arc 135a formed by baffle wire 120a in a manner which is preferably similar to the manner in which the covering 44, foam 42, electrodes 40, leads 39, baffle wire 20, and infusion tube 36 are arranged in the first embodiment . Reference is therefore made to Figs. 4 and 5 and the description thereof . Operation of the fourth embodiment of a linear lesion catheter 140 according to the present invention will next be described. To prepare the device for insertion into a patient's vessels, free end 136a of baffle wire 120a is pulled in a proximal direction to draw the arc 135a closer to the main shaft (see Fig. 14A) . The catheter 140 may be inserted into a conventional sheath catheter (not shown) so as to compress the ablation section 118a and the arc 135a close to the main shaft 116a to prevent these structures from snagging on tissue within the vessels and the heart . The sheath catheter is withdrawn to expose the ablation section 118 after the distal portion of the catheter 112a has been fed through the patient's vessels and positioned in the desired chamber of the heart.
Once the ablation section 118a is within the heart chamber, free end 136a of baffle wire 120a is advanced in a distal direction, causing a portion of the baffle wire 120a to pass out of the main shaft via the hole 119a thereby increasing the size of the arc 135a. As the size of the arc increases, the arc and the main shaft push against opposing tissue surfaces Tl, T2 and thus leverage the ablation section 118a against the portion T2 of the endocardium on which a lesion is to be formed. (See Fig. 14C) . Pressing the ablation section 118a against the endocardium in this manner helps the ablation section 118a to conform to the surface of the endocardium and thus helps to ensure that sufficient contact is made between the ablation section 118 and the endocardium to create a continuous transmural lesion.
Once the ablation section is properly positioned and baffled against the appropriate section of the endocardium, saline and RF energy are delivered to the ablation section 118 as described with respect to the first and second embodiments. The procedure is repeated to create multiple lesions on the endocardium. It should be understood that the various features of the preferred embodiments need not be used in combination one other. For example, referring to Fig. 15A, a catheter 200 according to the present invention may be provided without a baffle wire as found in the previously described embodiments. Catheter 200 includes a main shaft 202 (preferably having a diameter of 7 French) and an ablation section 204 formed over the main shaft 202. At the ablation section 204, a plurality of electrodes 206 are coiled around the main shaft 202, and (also at the ablation section 204) a plurality of
spaced holes 208 are formed in the main shaft. A foam support structure 210 (which may be segmented as in prior embodiments) is formed around the main shaft and electrodes 206, and the support structure 210 is enclosed by a perforated covering 212. A core wire 214 extends through the central lumen of the main shaft 202. Wire 214 may alternatively be a pull wire of a type which may be used to steer the catheter 200 through a patient's vessels and heart. As shown in Fig. 15B, foam segments 210a may each be provided with separate coverings 212a, each of which is provided with a plurality of holes 211 along one side. It is desirable to provide four such 20 mm wide segments 210a, each spaced from the other segments 210a by approximately 1 mm. Preferable, multiple lumen tubing having the configuration shown in Figs. 12B and 12C is utilized, with each of the fluid lumen (see lumen 82a in Figs. 12B and 12C) directing fluid from one of the fluid portions 88a - 88d to one of the foam segments 210a.
During use the catheter 200 is inserted via vessels into a chamber of the heart, and positioned against the endocardial surface. Saline S is introduced into the central lumen of main shaft 202 (which in this embodiment serves as the infusion tube) and passes through the holes 208 into the foam structure 210. RF energy is delivered to the electrodes 206 via lead wires (not shown) as described with respect to previous embodiments . The outward pressure of the saline S within covering 212 causes the covering 212 to balloon out slightly and thereby improves contact between the ablation section 204 and the endocardium. Saline passes from the foam out of the ablation section via the perforations (not shown) in the covering 212 and
in doing so creates an improved path of conductivity between the electrodes 206 and the endocardium.
As mentioned above, the foam support structure of the Fig. 15A embodiment and the previous embodiments may be replaced by other support structures which can press the covering of the ablation section against the endocardial wall during use. For example, small inflatable balloons 215 (Fig. 16) may be positioned inside the covering 212 and provided with inflation tubes 216 which provide flow paths for the introduction of an inflation medium (such as air or fluid) into the balloons 215 during use. Alternatively, the foam and covering may be eliminated from the apparatus as shown in Fig. 17, in which case the conductive fluid or saline flows through openings 208 in the main shaft and is utilized primarily to cool the ablation electrodes 206, although it may also create a conductive path between the electrodes and target tissue. The electrodes 206 may be formed into coils, braids, or other configurations.
A preferred embodiment and several alternative embodiments of a linear lesion catheter have been described herein. It should be appreciated that these embodiments have been given by way as example and are not intended to limit the scope of the appended claims.
Claims
CLAIMS 1. An apparatus for creating linear lesions in body tissue, the apparatus comprising: an elongate support member proportioned for insertion and manipulation through human vessels, the support member having an elongate ablation section; at least one electrode carried by the ablation section of the support member; a fluid permeable deformable member at least partially covering the electrodes; means for delivering current to the electrodes; and means for delivering conductive fluid through the deformable member to the ablation section to cause said fluid to create a conductive path between the electrodes and the tissue when the electrodes are positioned adjacent body tissue.
2. The apparatus of claim 1 wherein the deformable member includes a layer of foam material formed over the electrodes.
3. The apparatus of claim 1 wherein the deformable member is segmented.
4. The apparatus of claim 1, further comprising a covering on the deformable member, the covering formed of a material substantially impermeable to fluid, the covering including at least one opening sized to allow passage of fluid out of the covering.
5. The apparatus of claim 4 wherein the covering includes a plurality of spaced openings positioned longitudinally along one side of the ablation section.
6. The apparatus of claim 1 wherein the deformable layer is provided in segments and wherein the apparatus further comprises a plurality of coverings, each covering one of the segments.
7. An apparatus for creating lesions in body tissue, the apparatus comprising: an elongate wire having an ablation section; a plurality of spaced electrodes carried by the ablation section of the wire; a covering at least partially overlaying the electrodes, the covering formed of a material substantially impermeable to fluid, the covering including at least one opening sized to allow passage of fluid out of the covering; means for delivering current to the electrodes; and means for delivering conductive fluid to the ablation section to cause said fluid to create a conductive path between the electrodes and the tissue when the electrodes are positioned adjacent body tissue.
8. The apparatus of claim 7 further comprising means for supporting the covering away from the electrodes.
9. The apparatus of claim 8 wherein the supporting means includes a deformable member positioned between the electrodes and the covering, the deformable member being fluid permeable.
10. The apparatus of claim 9 wherein the deformable member includes a layer of foam formed over the electrodes .
11. The apparatus of claim 8 wherein the supporting means includes an inflatable balloon positioned beneath the covering and means for delivering an inflation medium to the inflatable balloon.
12. A method for ablating body tissue, comprising the steps of:
(a) providing an elongate member, electrodes carried by the member, a deformable layer of fluid permeable material formed over the electrodes, and means for delivering conductive fluid to the electrodes;
(b) manipulating the member through a vessel and into the chamber of a heart, and positioning the layer adjacent to a wall within the heart which is to be ablated;
(c) supplying current to the electrodes;
(d) supplying conductive fluid to the electrodes; and (e) permitting the conductive fluid to form a conductive path between the electrodes and the tissue which is to be ablated.
13. The method of claim 12 wherein step (a) further includes the step of providing a covering the deformable layer, the covering formed of a material substantially impermeable to fluid, the covering including at least one opening sized to allow passage of fluid out of the covering, and wherein step (b) further includes the step of positioning the deformable layer, with the covering overlaying it, against the body tissue which is to ablated.
14. An apparatus for ablating body tissue, comprising: an elongate tubular member having an opening; a baffle member having a distal portion slidably disposed within the tubular member, the baffle member slidable between a first position in which the distal portion extends from the opening and is folded over itself, and a second position in which the distal portion of the baffle member is contained within the elongate tubular member; and an ablation element carried by the baffle member.
15. The apparatus of claim 14 wherein the baffle member includes a fixed distal end attached to the tubular member and a free proximal end slidable relative to the tubular member to move the baffle member between the first and second positions.
16. The apparatus of claim 14 wherein the baffle member has a substantially flat cross-section.
17. The apparatus of claim 15 wherein: the apparatus further comprises a second tube, wherein a portion of the baffle member is slidably received within the second tube; the ablation element is carried by the second tube; and when the baffle member is in the first position, the second tube is slidable over the loop to reposition the ablation element with respect to the loop.
18. The apparatus of claim 14 wherein the baffle member includes a pair of free ends, each slidable to move the baffle member between the first and second positions.
19. A method of forming a linear lesion, comprising the steps of:
(a) providing an elongate tubular member having a distal portion, an opening at the distal portion, a loop positioned within the distal portion and moveable through the opening to a position outside the distal portion, and an ablation element carried by the loop;
(b) with the loop inside the tubular member, inserting the distal portion of the tubular member through an incision and into a patient, and positioning the opening adjacent to target tissue to be ablated;
(c) extending the loop from the distal portion; (d) positioning the ablation element against the target tissue;
(e) positioning a portion of the loop which is spaced from the ablation element against a tissue surface opposing the target tissue to leverage the electrode against the target tissue; and
(f) ablating the tissue using the ablation element .
20. The method of claim 19 wherein step (e) includes the step of increasing or decreasing the size of the loop.
21. The method of claim 19 wherein: step (a) includes providing a tubular member slidably disposed on the loop and providing the ablation element on the tubular member; and step (d) includes the step of sliding the tubular member along the loop to adjust the position of the ablation element with respect to the loop.
22. The method of claim 21 further including the step of, after step (f) , sliding the tubular member along the loop to reposition the ablation element adjacent to second target tissue, and ablating the second target tissue using the ablation element.
23. The method of claim 19 wherein: in step (a) the step of providing a loop includes providing a baffle member having a fixed end attached to the tubular member, an intermediate portion folded over itself to form the loop, and a free end movable to effect sliding of the baffle wire to move the loop into and out of the tubular member and to change the size of the loop; step (c) includes the step of advancing the free end distally to extend the loop from the tubular member; steps (d) and (e) include the step of moving the free end distally or proximally as needed to increase or decrease the size of the loop.
24. The method of claim 23 wherein: step (a) further comprises the step of providing a tubular member slidably disposed on the baffle wire and providing the ablation element on the tubular member; and step (d) includes the step of sliding the tubular member along the loop to adjust the position of the ablation element with respect to the loop.
25. The method of claim 25 further including the step of, after step (f) , sliding the tubular member along the loop to reposition the ablation element adjacent to second target tissue, and ablating the second target tissue using the ablation element .
26. The method of claim 20 wherein: in step (a) the step of providing a loop includes providing a baffle member having a pair of free ends and an intermediate portion between the ends and folded over itself to form the loop, the free ends movable to effect sliding of the baffle wire to move the loop into and out of the tubular member and to change the size of the loop; step (c) includes the step of advancing at least one of the free ends distally to extend the loop from the tubular member; and steps (d) and (e) include the step of moving at least one of the free ends distally or proximally as needed to increase or decrease the size of the loop.
27. An assembly carried on the distal end of a catheter for generating a linear lesion in a target tissue comprising: a central, elongated support member; a plurality of longitudinally spaced apart electrodes, said electrodes being connectable to a source of RF energy; an elongated, deformable member surrounding said electrodes and a portion of said support member; and a source of electrolytic fluid coupled to said deformable member, said fluid functioning to partially pressurize said deformable member and wherein said fluid perfuses out of said deformable member towards the target tissue, said fluid enhancing the coupling of the RF energy from said electrodes to said tissue whereby linear lesions can be effectively created in said tissue.
28. An assembly as recited in claim 27 wherein said deformable member is formed in longitudinal segments corresponding to, and aligned with, the electrodes on said support member.
28. An assembly as recited in claim 27 wherein said support member is a wire.
29. An assembly as recited in claim 27 wherein said deformable member is formed from foam surrounded by an outer membrane having apertures formed therein.
30. An assembly as recited in claim 27 wherein said deformable member includes an inflatable balloon, an outer membrane enclosing the balloon and having apertures formed therein, and means for delivering an inflation medium to the inflatable balloon.
31. An assembly as recited in claim 27 further including a means for biasing said deformable member into contact with the target tissue.
32. An assembly as recited in claim 31 further comprising an elongate tubular member having an opening, wherein the central support member is slidably disposed within the elongate tubular member and wherein the central support member is slidable between a first position in which the distal portion extends from the opening and is folded over itself, and a second position in which the distal portion of the baffle member is contained within the elongate tubular member, wherein the biasing means includes the central support member, and wherein the electrodes and the deformable member are carried by the central support member.
33. An assembly carried on the distal end of a catheter for generating a linear lesion in a target tissue comprising: a central, elongated support member; a plurality of longitudinally spaced apart electrodes carried by the support member, said electrodes being connectable to a source of RF energy; and means carried by the support member for directing electrolytic fluid onto said electrodes.
AMENDED CLAIMS
[received by the International Bureau on 15 July 1997(15.07.97); original claim 32 amended; new claims 34-38 added; remaining claims unchanged (3 pages)] deformable member towards the target tissue, said fluid enhancing the coupling of the RF energy from said electrodes to said tissue whereby linear lesions can be effectively created in said tissue.
28. An assembly as recited in claim 27 wherein said deformable member is formed in longitudinal segments corresponding to, and aligned with, the electrodes on said support member.
28. An assembly as recited in claim 27 wherein said support member is a wire.
29. An assembly as recited in claim 27 wherein said deformable member is formed from foam surrounded by an outer membrane having apertures formed therein.
30. An assembly as recited in claim 27 wherein said deformable member includes an inflatable balloon, an outer membrane enclosing the balloon and having apertures formed therein, and means for delivering an inflation medium to the inflatable balloon.
31. An assembly as recited in claim 27 further including a means for biasing said deformable member into contact with the target tissue.
32. An assembly as recited in claim 31 further comprising an elongate' tubular member having an opening, wherein the central support member is slidably disposed within the elongate tubular member and wherein the central support member is slidable between a first position in which the distal portion extends from the opening and is folded over itself, and a second position in which the distal portion of the central support member is contained within the elongate tubular member, wherein the biasing means includes the central support member, and wherein the electrodes and the deformable member are carried by the central support member.
33. An assembly carried on the distal end of a catheter for generating a linear lesion in a target tissue comprising: a central, elongated support member; a plurality of longitudinally spaced apart electrodes carried by the support member, said electrodes being connectable to a source of RF energy; and means carried by the support member for directing electrolytic fluid onto said electrodes.
34. An apparatus for forming linear lesions in body tissue, comprising: a first tubular member; a loop member slidably disposed within the first tubular member, at least one of the first tubular member and loop member slidable to alter the position of the first tubular member relative to the loop member; a plurality of longitudinally spaced apart electrodes carried by the first tubular member, said electrodes being connectable to a source of RF energy; a fluid lumen carried by the first tubular member for directing electrolytic fluid onto said electrodes; and an elongated deformable member surrounding the electrodes and a portion of the first tubular member.
35. The apparatus of claim 34, further comprising: a covering on the deformable member, the covering formed of a material substantially impermeable to fluid, the covering including at least one opening sized to allow passage of fluid out of the covering.
36. The apparatus of claim 34 further comprising: a second tubular member, wherein at least a portion of the first tubular member and the loop member are slidably disposed within the second tubular member.
37. The apparatus of claim 34 wherein the electrodes are located on the exterior of the first tubular member.
38. The apparatus of claim 34 wherein the electrodes are positioned in the fluid lumen.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE69610566T DE69610566T2 (en) | 1996-03-06 | 1996-11-04 | ABLATION DEVICE FOR GENERATING LINEAR LESIONS |
JP09531745A JP2000506751A (en) | 1996-03-06 | 1996-11-04 | Apparatus for forming linear lesions by resection |
EP96937859A EP0884978B1 (en) | 1996-03-06 | 1996-11-04 | Apparatus for creating linear lesions by ablation |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/611,656 US5800482A (en) | 1996-03-06 | 1996-03-06 | Apparatus and method for linear lesion ablation |
US08/611,656 | 1996-03-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1997032525A1 true WO1997032525A1 (en) | 1997-09-12 |
Family
ID=24449908
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1996/017536 WO1997032525A1 (en) | 1996-03-06 | 1996-11-04 | Apparatus for creating linear lesions by ablation |
Country Status (5)
Country | Link |
---|---|
US (2) | US5800482A (en) |
EP (1) | EP0884978B1 (en) |
JP (1) | JP2000506751A (en) |
DE (1) | DE69610566T2 (en) |
WO (1) | WO1997032525A1 (en) |
Cited By (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999048421A1 (en) * | 1998-03-27 | 1999-09-30 | Cardiac Pathways Corporation | Combination of linear ablation and cooled tip rf catheters |
WO1999056812A2 (en) * | 1998-05-06 | 1999-11-11 | Atrionix, Inc. | Irrigated ablation device assembly |
WO2002019934A1 (en) | 2000-09-08 | 2002-03-14 | Atrionx, Inc. | Medical device with sensor cooperating with expandable member |
US6475179B1 (en) | 2000-11-10 | 2002-11-05 | New England Medical Center | Tissue folding device for tissue ablation, and method thereof |
US6527767B2 (en) | 1998-05-20 | 2003-03-04 | New England Medical Center | Cardiac ablation system and method for treatment of cardiac arrhythmias and transmyocardial revascularization |
US6964660B2 (en) * | 1997-07-08 | 2005-11-15 | Atrionix, Inc. | Tissue ablation device assembly and method of electrically isolating a pulmonary vein ostium from an atrial wall |
WO2007019876A1 (en) | 2005-08-19 | 2007-02-22 | De Neve Werner Francois | Device and method for assisting heat ablation treatment of the heart |
US7211055B2 (en) | 2002-01-15 | 2007-05-01 | The Regents Of The University Of California | System and method providing directional ultrasound therapy to skeletal joints |
US7247269B2 (en) | 2003-07-21 | 2007-07-24 | Biosense Webster, Inc. | Method for making a spiral array ultrasound transducer |
US7655005B2 (en) | 2003-12-31 | 2010-02-02 | Biosense Webster, Inc. | Circumferential ablation device assembly with dual expandable members |
US7670335B2 (en) | 2003-07-21 | 2010-03-02 | Biosense Webster, Inc. | Ablation device with spiral array ultrasound transducer |
US7850685B2 (en) | 2005-06-20 | 2010-12-14 | Medtronic Ablation Frontiers Llc | Ablation catheter |
US8273084B2 (en) | 2004-11-24 | 2012-09-25 | Medtronic Ablation Frontiers Llc | Atrial ablation catheter and method of use |
US8414509B2 (en) | 2002-01-23 | 2013-04-09 | The Regents Of The University Of California | Implantable thermal treatment method and apparatus |
US8486063B2 (en) | 2004-10-14 | 2013-07-16 | Medtronic Ablation Frontiers Llc | Ablation catheter |
US8617152B2 (en) | 2004-11-15 | 2013-12-31 | Medtronic Ablation Frontiers Llc | Ablation system with feedback |
US8641704B2 (en) | 2007-05-11 | 2014-02-04 | Medtronic Ablation Frontiers Llc | Ablation therapy system and method for treating continuous atrial fibrillation |
US8657814B2 (en) | 2005-08-22 | 2014-02-25 | Medtronic Ablation Frontiers Llc | User interface for tissue ablation system |
US8728073B2 (en) | 2006-10-10 | 2014-05-20 | Biosense Webster, Inc. | Multi-region staged inflation balloon |
US8834461B2 (en) | 2005-07-11 | 2014-09-16 | Medtronic Ablation Frontiers Llc | Low power tissue ablation system |
US8864758B2 (en) | 2003-01-21 | 2014-10-21 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Catheter design that facilitates positioning at tissue to be diagnosed or treated |
US8932208B2 (en) | 2005-05-26 | 2015-01-13 | Maquet Cardiovascular Llc | Apparatus and methods for performing minimally-invasive surgical procedures |
US9005194B2 (en) | 2004-11-24 | 2015-04-14 | Medtronic Ablation Frontiers Llc | Atrial ablation catheter adapted for treatment of septal wall arrhythmogenic foci and method of use |
EP2881057A1 (en) | 2013-12-05 | 2015-06-10 | Region Nordjylland | Apparatus for creating linear lesions in body tissue within a body vessel |
US9055959B2 (en) | 1999-07-19 | 2015-06-16 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Methods and devices for ablation |
US9265563B2 (en) | 2006-02-22 | 2016-02-23 | Custom Medical Applications, Inc. | Ablation instruments and related methods |
US10058380B2 (en) | 2007-10-05 | 2018-08-28 | Maquet Cordiovascular Llc | Devices and methods for minimally-invasive surgical procedures |
Families Citing this family (353)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5820591A (en) * | 1990-02-02 | 1998-10-13 | E. P. Technologies, Inc. | Assemblies for creating compound curves in distal catheter regions |
US6161543A (en) | 1993-02-22 | 2000-12-19 | Epicor, Inc. | Methods of epicardial ablation for creating a lesion around the pulmonary veins |
ES2260758T3 (en) * | 1993-10-14 | 2006-11-01 | Boston Scientific Limited | ELECTRODE ELEMENTS TO FORM INJURY PATTERNS. |
US5582609A (en) | 1993-10-14 | 1996-12-10 | Ep Technologies, Inc. | Systems and methods for forming large lesions in body tissue using curvilinear electrode elements |
US6146379A (en) * | 1993-10-15 | 2000-11-14 | Ep Technologies, Inc. | Systems and methods for creating curvilinear lesions in body tissue |
US5575810A (en) * | 1993-10-15 | 1996-11-19 | Ep Technologies, Inc. | Composite structures and methods for ablating tissue to form complex lesion patterns in the treatment of cardiac conditions and the like |
US6001093A (en) | 1993-10-15 | 1999-12-14 | Ep Technologies, Inc. | Systems and methods for creating long, thin lesions in body tissue |
WO1995010320A1 (en) | 1993-10-15 | 1995-04-20 | Ep Technologies, Inc. | Device for lengthening cardiac conduction pathways |
US5536267A (en) | 1993-11-08 | 1996-07-16 | Zomed International | Multiple electrode ablation apparatus |
US6632221B1 (en) | 1993-11-08 | 2003-10-14 | Rita Medical Systems, Inc. | Method of creating a lesion in tissue with infusion |
US6569159B1 (en) | 1993-11-08 | 2003-05-27 | Rita Medical Systems, Inc. | Cell necrosis apparatus |
US6641580B1 (en) * | 1993-11-08 | 2003-11-04 | Rita Medical Systems, Inc. | Infusion array ablation apparatus |
US5746224A (en) * | 1994-06-24 | 1998-05-05 | Somnus Medical Technologies, Inc. | Method for ablating turbinates |
US8025661B2 (en) | 1994-09-09 | 2011-09-27 | Cardiofocus, Inc. | Coaxial catheter instruments for ablation with radiant energy |
US6676656B2 (en) | 1994-09-09 | 2004-01-13 | Cardiofocus, Inc. | Surgical ablation with radiant energy |
US6558375B1 (en) | 2000-07-14 | 2003-05-06 | Cardiofocus, Inc. | Cardiac ablation instrument |
US6579285B2 (en) | 1994-09-09 | 2003-06-17 | Cardiofocus, Inc. | Photoablation with infrared radiation |
US6572609B1 (en) | 1999-07-14 | 2003-06-03 | Cardiofocus, Inc. | Phototherapeutic waveguide apparatus |
US6423055B1 (en) | 1999-07-14 | 2002-07-23 | Cardiofocus, Inc. | Phototherapeutic wave guide apparatus |
US7175619B2 (en) * | 1994-10-07 | 2007-02-13 | Boston Scientific Scimed, Inc. | Loop structures for positioning a diagnostic or therapeutic element on the epicardium or other organ surface |
US6071274A (en) * | 1996-12-19 | 2000-06-06 | Ep Technologies, Inc. | Loop structures for supporting multiple electrode elements |
US6464700B1 (en) | 1994-10-07 | 2002-10-15 | Scimed Life Systems, Inc. | Loop structures for positioning a diagnostic or therapeutic element on the epicardium or other organ surface |
US5814029A (en) * | 1994-11-03 | 1998-09-29 | Daig Corporation | Guiding introducer system for use in ablation and mapping procedures in the left ventricle |
US5897553A (en) | 1995-11-02 | 1999-04-27 | Medtronic, Inc. | Ball point fluid-assisted electrocautery device |
US6409722B1 (en) | 1998-07-07 | 2002-06-25 | Medtronic, Inc. | Apparatus and method for creating, maintaining, and controlling a virtual electrode used for the ablation of tissue |
US6053937A (en) * | 1995-08-15 | 2000-04-25 | Rita Medical Systems, Inc. | Multiple electrode ablation apparatus and method with cooling element |
US6059780A (en) | 1995-08-15 | 2000-05-09 | Rita Medical Systems, Inc. | Multiple antenna ablation apparatus and method with cooling element |
US5800482A (en) * | 1996-03-06 | 1998-09-01 | Cardiac Pathways Corporation | Apparatus and method for linear lesion ablation |
US7604633B2 (en) | 1996-04-12 | 2009-10-20 | Cytyc Corporation | Moisture transport system for contact electrocoagulation |
US6813520B2 (en) | 1996-04-12 | 2004-11-02 | Novacept | Method for ablating and/or coagulating tissue using moisture transport |
GB9609866D0 (en) | 1996-05-11 | 1996-07-17 | Morgan John M | Ablation catheter |
US8353908B2 (en) | 1996-09-20 | 2013-01-15 | Novasys Medical, Inc. | Treatment of tissue in sphincters, sinuses, and orifices |
US6805128B1 (en) | 1996-10-22 | 2004-10-19 | Epicor Medical, Inc. | Apparatus and method for ablating tissue |
US6719755B2 (en) | 1996-10-22 | 2004-04-13 | Epicor Medical, Inc. | Methods and devices for ablation |
US6311692B1 (en) | 1996-10-22 | 2001-11-06 | Epicor, Inc. | Apparatus and method for diagnosis and therapy of electrophysiological disease |
US6237605B1 (en) * | 1996-10-22 | 2001-05-29 | Epicor, Inc. | Methods of epicardial ablation |
US6332880B1 (en) | 1996-12-19 | 2001-12-25 | Ep Technologies, Inc. | Loop structures for supporting multiple electrode elements |
US6203525B1 (en) | 1996-12-19 | 2001-03-20 | Ep Technologies, Inc. | Catheterdistal assembly with pull wires |
US6076012A (en) | 1996-12-19 | 2000-06-13 | Ep Technologies, Inc. | Structures for supporting porous electrode elements |
US6071279A (en) * | 1996-12-19 | 2000-06-06 | Ep Technologies, Inc. | Branched structures for supporting multiple electrode elements |
US6048329A (en) * | 1996-12-19 | 2000-04-11 | Ep Technologies, Inc. | Catheter distal assembly with pull wires |
US7591814B2 (en) | 1997-02-27 | 2009-09-22 | Cryocath Technologies Inc. | Extended treatment zone catheter |
US6669689B2 (en) * | 1997-02-27 | 2003-12-30 | Cryocath Technologies Inc. | Cryosurgical catheter |
US6235019B1 (en) | 1997-02-27 | 2001-05-22 | Cryocath Technologies, Inc. | Cryosurgical catheter |
US6602247B2 (en) | 1997-02-27 | 2003-08-05 | Cryocath Technologies Inc. | Apparatus and method for performing a treatment on a selected tissue region |
WO2000032126A1 (en) | 1997-02-27 | 2000-06-08 | Cryocath Technologies Inc. | Cryosurgical catheter |
US6251109B1 (en) | 1997-06-27 | 2001-06-26 | Daig Corporation | Process and device for the treatment of atrial arrhythmia |
US5938660A (en) | 1997-06-27 | 1999-08-17 | Daig Corporation | Process and device for the treatment of atrial arrhythmia |
US6096037A (en) | 1997-07-29 | 2000-08-01 | Medtronic, Inc. | Tissue sealing electrosurgery device and methods of sealing tissue |
US6080151A (en) | 1997-07-21 | 2000-06-27 | Daig Corporation | Ablation catheter |
DE69829921T2 (en) * | 1997-08-04 | 2006-05-04 | Ethicon, Inc. | Device for the treatment of body tissue |
US9023031B2 (en) | 1997-08-13 | 2015-05-05 | Verathon Inc. | Noninvasive devices, methods, and systems for modifying tissues |
US6464699B1 (en) | 1997-10-10 | 2002-10-15 | Scimed Life Systems, Inc. | Method and apparatus for positioning a diagnostic or therapeutic element on body tissue and mask element for use with same |
US6610055B1 (en) | 1997-10-10 | 2003-08-26 | Scimed Life Systems, Inc. | Surgical method for positioning a diagnostic or therapeutic element on the epicardium or other organ surface |
US6579288B1 (en) | 1997-10-10 | 2003-06-17 | Scimed Life Systems, Inc. | Fluid cooled apparatus for supporting diagnostic and therapeutic elements in contact with tissue |
US8709007B2 (en) | 1997-10-15 | 2014-04-29 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Devices and methods for ablating cardiac tissue |
US6176857B1 (en) | 1997-10-22 | 2001-01-23 | Oratec Interventions, Inc. | Method and apparatus for applying thermal energy to tissue asymmetrically |
US6120500A (en) * | 1997-11-12 | 2000-09-19 | Daig Corporation | Rail catheter ablation and mapping system |
US6358245B1 (en) | 1998-02-19 | 2002-03-19 | Curon Medical, Inc. | Graphical user interface for association with an electrode structure deployed in contact with a tissue region |
US8906010B2 (en) | 1998-02-19 | 2014-12-09 | Mederi Therapeutics, Inc. | Graphical user interface for association with an electrode structure deployed in contact with a tissue region |
US6273886B1 (en) * | 1998-02-19 | 2001-08-14 | Curon Medical, Inc. | Integrated tissue heating and cooling apparatus |
US7674259B2 (en) * | 2000-12-09 | 2010-03-09 | Tsunami Medtech | Medical instruments and techniques for thermally-mediated therapies |
US8016823B2 (en) | 2003-01-18 | 2011-09-13 | Tsunami Medtech, Llc | Medical instrument and method of use |
US7892229B2 (en) | 2003-01-18 | 2011-02-22 | Tsunami Medtech, Llc | Medical instruments and techniques for treating pulmonary disorders |
US6106518A (en) * | 1998-04-09 | 2000-08-22 | Cryocath Technologies, Inc. | Variable geometry tip for a cryosurgical ablation device |
US6493589B1 (en) | 1998-05-07 | 2002-12-10 | Medtronic, Inc. | Methods and apparatus for treatment of pulmonary conditions |
US6327505B1 (en) | 1998-05-07 | 2001-12-04 | Medtronic, Inc. | Method and apparatus for rf intraluminal reduction and occlusion |
US8551082B2 (en) | 1998-05-08 | 2013-10-08 | Cytyc Surgical Products | Radio-frequency generator for powering an ablation device |
US6837885B2 (en) * | 1998-05-22 | 2005-01-04 | Scimed Life Systems, Inc. | Surgical probe for supporting inflatable therapeutic devices in contact with tissue in or around body orifices and within tumors |
US6706039B2 (en) * | 1998-07-07 | 2004-03-16 | Medtronic, Inc. | Method and apparatus for creating a bi-polar virtual electrode used for the ablation of tissue |
US6302903B1 (en) | 1998-07-07 | 2001-10-16 | Medtronic, Inc. | Straight needle apparatus for creating a virtual electrode used for the ablation of tissue |
US6494902B2 (en) | 1998-07-07 | 2002-12-17 | Medtronic, Inc. | Method for creating a virtual electrode for the ablation of tissue and for selected protection of tissue during an ablation |
US6238393B1 (en) | 1998-07-07 | 2001-05-29 | Medtronic, Inc. | Method and apparatus for creating a bi-polar virtual electrode used for the ablation of tissue |
US6537272B2 (en) | 1998-07-07 | 2003-03-25 | Medtronic, Inc. | Apparatus and method for creating, maintaining, and controlling a virtual electrode used for the ablation of tissue |
US6315777B1 (en) | 1998-07-07 | 2001-11-13 | Medtronic, Inc. | Method and apparatus for creating a virtual electrode used for the ablation of tissue |
US6537248B2 (en) | 1998-07-07 | 2003-03-25 | Medtronic, Inc. | Helical needle apparatus for creating a virtual electrode used for the ablation of tissue |
US8308719B2 (en) | 1998-09-21 | 2012-11-13 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Apparatus and method for ablating tissue |
US6190382B1 (en) | 1998-12-14 | 2001-02-20 | Medwaves, Inc. | Radio-frequency based catheter system for ablation of body tissues |
US20070066972A1 (en) * | 2001-11-29 | 2007-03-22 | Medwaves, Inc. | Ablation catheter apparatus with one or more electrodes |
US6217528B1 (en) * | 1999-02-11 | 2001-04-17 | Scimed Life Systems, Inc. | Loop structure having improved tissue contact capability |
US6358273B1 (en) | 1999-04-09 | 2002-03-19 | Oratec Inventions, Inc. | Soft tissue heating apparatus with independent, cooperative heating sources |
US6463331B1 (en) * | 1999-04-19 | 2002-10-08 | Novasys Medical, Inc. | Application of energy and substances in the treatment of uro-genital disorders |
US8540704B2 (en) | 1999-07-14 | 2013-09-24 | Cardiofocus, Inc. | Guided cardiac ablation catheters |
US9033961B2 (en) | 1999-07-14 | 2015-05-19 | Cardiofocus, Inc. | Cardiac ablation catheters for forming overlapping lesions |
US8900219B2 (en) | 1999-07-14 | 2014-12-02 | Cardiofocus, Inc. | System and method for visualizing tissue during ablation procedures |
US7935108B2 (en) | 1999-07-14 | 2011-05-03 | Cardiofocus, Inc. | Deflectable sheath catheters |
EP1207788A4 (en) | 1999-07-19 | 2009-12-09 | St Jude Medical Atrial Fibrill | Apparatus and method for ablating tissue |
US6852120B1 (en) * | 1999-08-10 | 2005-02-08 | Biosense Webster, Inc | Irrigation probe for ablation during open heart surgery |
US20040147911A1 (en) * | 1999-08-25 | 2004-07-29 | Cardiofocus, Inc. | Surgical ablation instruments for forming an encircling lesion |
US6773432B1 (en) * | 1999-10-14 | 2004-08-10 | Applied Medical Resources Corporation | Electrosurgical snare |
US6529756B1 (en) * | 1999-11-22 | 2003-03-04 | Scimed Life Systems, Inc. | Apparatus for mapping and coagulating soft tissue in or around body orifices |
US6645199B1 (en) | 1999-11-22 | 2003-11-11 | Scimed Life Systems, Inc. | Loop structures for supporting diagnostic and therapeutic elements contact with body tissue and expandable push devices for use with same |
US6542781B1 (en) | 1999-11-22 | 2003-04-01 | Scimed Life Systems, Inc. | Loop structures for supporting diagnostic and therapeutic elements in contact with body tissue |
US6613046B1 (en) | 1999-11-22 | 2003-09-02 | Scimed Life Systems, Inc. | Loop structures for supporting diagnostic and therapeutic elements in contact with body tissue |
US7097641B1 (en) * | 1999-12-09 | 2006-08-29 | Cryocath Technologies Inc. | Catheter with cryogenic and heating ablation |
US7706882B2 (en) | 2000-01-19 | 2010-04-27 | Medtronic, Inc. | Methods of using high intensity focused ultrasound to form an ablated tissue area |
US6692450B1 (en) | 2000-01-19 | 2004-02-17 | Medtronic Xomed, Inc. | Focused ultrasound ablation devices having selectively actuatable ultrasound emitting elements and methods of using the same |
US6595934B1 (en) | 2000-01-19 | 2003-07-22 | Medtronic Xomed, Inc. | Methods of skin rejuvenation using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions |
US6413254B1 (en) | 2000-01-19 | 2002-07-02 | Medtronic Xomed, Inc. | Method of tongue reduction by thermal ablation using high intensity focused ultrasound |
US8221402B2 (en) | 2000-01-19 | 2012-07-17 | Medtronic, Inc. | Method for guiding a medical device |
US6409720B1 (en) | 2000-01-19 | 2002-06-25 | Medtronic Xomed, Inc. | Methods of tongue reduction using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions |
US6361531B1 (en) | 2000-01-21 | 2002-03-26 | Medtronic Xomed, Inc. | Focused ultrasound ablation devices having malleable handle shafts and methods of using the same |
US6689131B2 (en) | 2001-03-08 | 2004-02-10 | Tissuelink Medical, Inc. | Electrosurgical device having a tissue reduction sensor |
US6558385B1 (en) | 2000-09-22 | 2003-05-06 | Tissuelink Medical, Inc. | Fluid-assisted medical device |
US7811282B2 (en) | 2000-03-06 | 2010-10-12 | Salient Surgical Technologies, Inc. | Fluid-assisted electrosurgical devices, electrosurgical unit with pump and methods of use thereof |
US8048070B2 (en) | 2000-03-06 | 2011-11-01 | Salient Surgical Technologies, Inc. | Fluid-assisted medical devices, systems and methods |
EP1946716B1 (en) | 2000-03-06 | 2017-07-19 | Salient Surgical Technologies, Inc. | Fluid delivery system and controller for electrosurgical devices |
US6953461B2 (en) | 2002-05-16 | 2005-10-11 | Tissuelink Medical, Inc. | Fluid-assisted medical devices, systems and methods |
US6488680B1 (en) * | 2000-04-27 | 2002-12-03 | Medtronic, Inc. | Variable length electrodes for delivery of irrigated ablation |
WO2001082812A1 (en) | 2000-04-27 | 2001-11-08 | Medtronic, Inc. | Vibration sensitive ablation apparatus and method |
US6514250B1 (en) | 2000-04-27 | 2003-02-04 | Medtronic, Inc. | Suction stabilized epicardial ablation devices |
US6837886B2 (en) | 2000-05-03 | 2005-01-04 | C.R. Bard, Inc. | Apparatus and methods for mapping and ablation in electrophysiology procedures |
US6669692B1 (en) * | 2000-08-21 | 2003-12-30 | Biosense Webster, Inc. | Ablation catheter with cooled linear electrode |
US6942661B2 (en) * | 2000-08-30 | 2005-09-13 | Boston Scientific Scimed, Inc. | Fluid cooled apparatus for supporting diagnostic and therapeutic elements in contact with tissue |
US7306591B2 (en) | 2000-10-02 | 2007-12-11 | Novasys Medical, Inc. | Apparatus and methods for treating female urinary incontinence |
US6673063B2 (en) * | 2000-10-06 | 2004-01-06 | Expanding Concepts, Llc. | Epidural thermal posterior annuloplasty |
US20040006379A1 (en) * | 2000-10-06 | 2004-01-08 | Expanding Concepts, L.L.C. | Epidural thermal posterior annuloplasty |
US6926669B1 (en) | 2000-10-10 | 2005-08-09 | Medtronic, Inc. | Heart wall ablation/mapping catheter and method |
US6416513B1 (en) * | 2000-10-12 | 2002-07-09 | Scott Dresden | Configurable electrode instrument for use in loop electrical excision procedures |
US6916306B1 (en) * | 2000-11-10 | 2005-07-12 | Boston Scientific Scimed, Inc. | Steerable loop structures for supporting diagnostic and therapeutic elements in contact with body tissue |
US7785323B2 (en) * | 2000-12-04 | 2010-08-31 | Boston Scientific Scimed, Inc. | Loop structure including inflatable therapeutic device |
US9433457B2 (en) | 2000-12-09 | 2016-09-06 | Tsunami Medtech, Llc | Medical instruments and techniques for thermally-mediated therapies |
US7549987B2 (en) * | 2000-12-09 | 2009-06-23 | Tsunami Medtech, Llc | Thermotherapy device |
US7740623B2 (en) | 2001-01-13 | 2010-06-22 | Medtronic, Inc. | Devices and methods for interstitial injection of biologic agents into tissue |
US20040138621A1 (en) | 2003-01-14 | 2004-07-15 | Jahns Scott E. | Devices and methods for interstitial injection of biologic agents into tissue |
US6666858B2 (en) * | 2001-04-12 | 2003-12-23 | Scimed Life Systems, Inc. | Cryo balloon for atrial ablation |
US7250048B2 (en) * | 2001-04-26 | 2007-07-31 | Medtronic, Inc. | Ablation system and method of use |
US7959626B2 (en) | 2001-04-26 | 2011-06-14 | Medtronic, Inc. | Transmural ablation systems and methods |
US6699240B2 (en) | 2001-04-26 | 2004-03-02 | Medtronic, Inc. | Method and apparatus for tissue ablation |
US6989010B2 (en) | 2001-04-26 | 2006-01-24 | Medtronic, Inc. | Ablation system and method of use |
US6663627B2 (en) | 2001-04-26 | 2003-12-16 | Medtronic, Inc. | Ablation system and method of use |
US6807968B2 (en) | 2001-04-26 | 2004-10-26 | Medtronic, Inc. | Method and system for treatment of atrial tachyarrhythmias |
US7255695B2 (en) * | 2001-04-27 | 2007-08-14 | C.R. Bard, Inc. | Systems and methods for three-dimensional mapping of electrical activity |
US7727229B2 (en) * | 2001-05-01 | 2010-06-01 | C.R. Bard, Inc. | Method and apparatus for altering conduction properties in the heart and in adjacent vessels |
EP1435867B1 (en) | 2001-09-05 | 2010-11-17 | Salient Surgical Technologies, Inc. | Fluid-assisted medical devices and systems |
AU2002327779B2 (en) * | 2001-09-28 | 2008-06-26 | Angiodynamics, Inc. | Impedance controlled tissue ablation apparatus and method |
US6939350B2 (en) | 2001-10-22 | 2005-09-06 | Boston Scientific Scimed, Inc. | Apparatus for supporting diagnostic and therapeutic elements in contact with tissue including electrode cooling device |
ATE375127T1 (en) * | 2001-11-29 | 2007-10-15 | Medwaves Inc | HIGH FREQUENCY CATHETER SYSTEM WITH IMPROVED DEFLECTION AND CONTROL MECHANISMS |
US8444636B2 (en) | 2001-12-07 | 2013-05-21 | Tsunami Medtech, Llc | Medical instrument and method of use |
US7099717B2 (en) * | 2002-01-03 | 2006-08-29 | Afx Inc. | Catheter having improved steering |
US6893436B2 (en) * | 2002-01-03 | 2005-05-17 | Afx, Inc. | Ablation instrument having a flexible distal portion |
US7967816B2 (en) | 2002-01-25 | 2011-06-28 | Medtronic, Inc. | Fluid-assisted electrosurgical instrument with shapeable electrode |
ITBS20020039U1 (en) * | 2002-03-20 | 2003-09-22 | Fogazzi Di Venturelli Andrea & | CATHETER WITH FLEXIBLE COOLED ELECTRODE |
US7118566B2 (en) | 2002-05-16 | 2006-10-10 | Medtronic, Inc. | Device and method for needle-less interstitial injection of fluid for ablation of cardiac tissue |
US7294143B2 (en) | 2002-05-16 | 2007-11-13 | Medtronic, Inc. | Device and method for ablation of cardiac tissue |
US20040082947A1 (en) | 2002-10-25 | 2004-04-29 | The Regents Of The University Of Michigan | Ablation catheters |
US8475455B2 (en) | 2002-10-29 | 2013-07-02 | Medtronic Advanced Energy Llc | Fluid-assisted electrosurgical scissors and methods |
US7083620B2 (en) | 2002-10-30 | 2006-08-01 | Medtronic, Inc. | Electrosurgical hemostat |
US6984232B2 (en) * | 2003-01-17 | 2006-01-10 | St. Jude Medical, Daig Division, Inc. | Ablation catheter assembly having a virtual electrode comprising portholes |
US6960207B2 (en) * | 2003-01-21 | 2005-11-01 | St Jude Medical, Daig Division, Inc. | Ablation catheter having a virtual electrode comprising portholes and a porous conductor |
US7819866B2 (en) | 2003-01-21 | 2010-10-26 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Ablation catheter and electrode |
US6923808B2 (en) * | 2003-02-24 | 2005-08-02 | Boston Scientific Scimed, Inc. | Probes having helical and loop shaped inflatable therapeutic elements |
US20040186467A1 (en) * | 2003-03-21 | 2004-09-23 | Swanson David K. | Apparatus for maintaining contact between diagnostic and therapeutic elements and tissue and systems including the same |
JP4601943B2 (en) * | 2003-04-03 | 2010-12-22 | エシコン・エンド−サージェリィ・インコーポレイテッド | Endoscope |
US7497857B2 (en) | 2003-04-29 | 2009-03-03 | Medtronic, Inc. | Endocardial dispersive electrode for use with a monopolar RF ablation pen |
US7410422B2 (en) * | 2003-06-13 | 2008-08-12 | Harrah's Operating Company, Inc. | Unified player rewards |
US20050010202A1 (en) * | 2003-06-30 | 2005-01-13 | Ethicon, Inc. | Applicator for creating linear lesions for the treatment of atrial fibrillation |
US7037306B2 (en) * | 2003-06-30 | 2006-05-02 | Ethicon, Inc. | System for creating linear lesions for the treatment of atrial fibrillation |
US7789877B2 (en) * | 2003-07-02 | 2010-09-07 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Ablation catheter electrode arrangement |
US7101362B2 (en) * | 2003-07-02 | 2006-09-05 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Steerable and shapable catheter employing fluid force |
US7235070B2 (en) | 2003-07-02 | 2007-06-26 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Ablation fluid manifold for ablation catheter |
US7104989B2 (en) * | 2003-09-05 | 2006-09-12 | Medtronic, Inc. | RF ablation catheter including a virtual electrode assembly |
US7736362B2 (en) * | 2003-09-15 | 2010-06-15 | Boston Scientific Scimed, Inc. | Catheter balloons |
US7229437B2 (en) * | 2003-09-22 | 2007-06-12 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Medical device having integral traces and formed electrodes |
US8147486B2 (en) * | 2003-09-22 | 2012-04-03 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Medical device with flexible printed circuit |
US7234225B2 (en) * | 2003-09-22 | 2007-06-26 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Method for manufacturing medical device having embedded traces and formed electrodes |
US8579892B2 (en) | 2003-10-07 | 2013-11-12 | Tsunami Medtech, Llc | Medical system and method of use |
US8052676B2 (en) | 2003-12-02 | 2011-11-08 | Boston Scientific Scimed, Inc. | Surgical methods and apparatus for stimulating tissue |
US7608072B2 (en) | 2003-12-02 | 2009-10-27 | Boston Scientific Scimed, Inc. | Surgical methods and apparatus for maintaining contact between tissue and electrophysiology elements and confirming whether a therapeutic lesion has been formed |
US20050267467A1 (en) * | 2004-01-16 | 2005-12-01 | Saurav Paul | Bipolar conforming electrode catheter and methods for ablation |
US7727232B1 (en) | 2004-02-04 | 2010-06-01 | Salient Surgical Technologies, Inc. | Fluid-assisted medical devices and methods |
US7371233B2 (en) | 2004-02-19 | 2008-05-13 | Boston Scientific Scimed, Inc. | Cooled probes and apparatus for maintaining contact between cooled probes and tissue |
US7291142B2 (en) * | 2004-05-10 | 2007-11-06 | Boston Scientific Scimed, Inc. | Low temperature lesion formation apparatus, systems and methods |
US7582083B2 (en) * | 2004-05-10 | 2009-09-01 | Boston Scientific Scimed, Inc. | Probe based low temperature lesion formation apparatus, systems and methods |
US7288088B2 (en) | 2004-05-10 | 2007-10-30 | Boston Scientific Scimed, Inc. | Clamp based low temperature lesion formation apparatus, systems and methods |
US8333764B2 (en) | 2004-05-12 | 2012-12-18 | Medtronic, Inc. | Device and method for determining tissue thickness and creating cardiac ablation lesions |
ES2308505T3 (en) | 2004-05-14 | 2008-12-01 | Medtronic, Inc. | ULTRASONIC ENERGY USE SYSTEM FOCUSED ON HIGH INTENS IDAD TO FORM A CUTTED FABRIC AREA. |
WO2005112814A2 (en) * | 2004-05-17 | 2005-12-01 | C.R. Bard, Inc. | Irrigated catheter |
WO2005112813A1 (en) | 2004-05-17 | 2005-12-01 | C.R. Bard, Inc. | Method and apparatus for mapping and7or ablation of cardiac tissue |
US7331959B2 (en) | 2004-05-27 | 2008-02-19 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Catheter electrode and rail system for cardiac ablation |
US10863945B2 (en) | 2004-05-28 | 2020-12-15 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Robotic surgical system with contact sensing feature |
US7632265B2 (en) | 2004-05-28 | 2009-12-15 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Radio frequency ablation servo catheter and method |
US7974674B2 (en) | 2004-05-28 | 2011-07-05 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Robotic surgical system and method for surface modeling |
US8528565B2 (en) | 2004-05-28 | 2013-09-10 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Robotic surgical system and method for automated therapy delivery |
US10258285B2 (en) | 2004-05-28 | 2019-04-16 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Robotic surgical system and method for automated creation of ablation lesions |
US9782130B2 (en) | 2004-05-28 | 2017-10-10 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Robotic surgical system |
US8755864B2 (en) | 2004-05-28 | 2014-06-17 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Robotic surgical system and method for diagnostic data mapping |
EP1750608B1 (en) | 2004-06-02 | 2012-10-03 | Medtronic, Inc. | Ablation device with jaws |
EP1750607A2 (en) * | 2004-06-02 | 2007-02-14 | Medtronic, Inc. | Loop ablation apparatus and method |
WO2005120377A1 (en) | 2004-06-02 | 2005-12-22 | Medtronic, Inc. | Clamping ablation tool |
DE602005021096D1 (en) | 2004-06-02 | 2010-06-17 | Medtronic Inc | COMPOUND BIPOLAR ABLATION DEVICE |
US8663245B2 (en) | 2004-06-18 | 2014-03-04 | Medtronic, Inc. | Device for occlusion of a left atrial appendage |
US8926635B2 (en) * | 2004-06-18 | 2015-01-06 | Medtronic, Inc. | Methods and devices for occlusion of an atrial appendage |
US8409219B2 (en) | 2004-06-18 | 2013-04-02 | Medtronic, Inc. | Method and system for placement of electrical lead inside heart |
JP5020824B2 (en) | 2004-11-16 | 2012-09-05 | ロバート・エル・バリー | Lung therapy apparatus and method |
US7731715B2 (en) * | 2004-12-10 | 2010-06-08 | Edwards Lifesciences Corporation | Ablative treatment of atrial fibrillation via the coronary sinus |
US7731712B2 (en) | 2004-12-20 | 2010-06-08 | Cytyc Corporation | Method and system for transcervical tubal occlusion |
US7674256B2 (en) | 2005-03-17 | 2010-03-09 | Boston Scientific Scimed, Inc. | Treating internal body tissue |
US20060253025A1 (en) * | 2005-04-21 | 2006-11-09 | Kaufman Jonathan J | Ultrasonic Bone Assessment Apparatus and Method |
US7674260B2 (en) | 2005-04-28 | 2010-03-09 | Cytyc Corporation | Emergency hemostasis device utilizing energy |
US8155910B2 (en) | 2005-05-27 | 2012-04-10 | St. Jude Medical, Atrial Fibrillation Divison, Inc. | Robotically controlled catheter and method of its calibration |
US8016822B2 (en) | 2005-05-28 | 2011-09-13 | Boston Scientific Scimed, Inc. | Fluid injecting devices and methods and apparatus for maintaining contact between fluid injecting devices and tissue |
US7776034B2 (en) * | 2005-06-15 | 2010-08-17 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Ablation catheter with adjustable virtual electrode |
US7419486B2 (en) * | 2005-06-15 | 2008-09-02 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Treatment and diagnostic catheters with hydrogel electrodes |
US7819868B2 (en) | 2005-06-21 | 2010-10-26 | St. Jude Medical, Atrial Fibrilation Division, Inc. | Ablation catheter with fluid distribution structures |
US20070021743A1 (en) * | 2005-07-22 | 2007-01-25 | Boston Scientific Scimed, Inc. | Compressible/expandable hydrophilic ablation electrode |
US7879030B2 (en) * | 2005-07-27 | 2011-02-01 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Multipolar, virtual-electrode catheter with at least one surface electrode and method for ablation |
US20070032785A1 (en) | 2005-08-03 | 2007-02-08 | Jennifer Diederich | Tissue evacuation device |
US7416552B2 (en) | 2005-08-22 | 2008-08-26 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Multipolar, multi-lumen, virtual-electrode catheter with at least one surface electrode and method for ablation |
US20080039746A1 (en) | 2006-05-25 | 2008-02-14 | Medtronic, Inc. | Methods of using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions |
US9414883B2 (en) * | 2006-06-09 | 2016-08-16 | Boston Scientific Scimed, Inc. | Co-access foam/electrode introducer |
US7865248B2 (en) * | 2006-06-15 | 2011-01-04 | Cardiac Pacemakers, Inc. | Biasing and fixation features on leads |
US8486060B2 (en) | 2006-09-18 | 2013-07-16 | Cytyc Corporation | Power ramping during RF ablation |
US7993323B2 (en) * | 2006-11-13 | 2011-08-09 | Uptake Medical Corp. | High pressure and high temperature vapor catheters and systems |
US7846160B2 (en) | 2006-12-21 | 2010-12-07 | Cytyc Corporation | Method and apparatus for sterilization |
US10932848B2 (en) | 2007-02-06 | 2021-03-02 | Microcube, Llc | Delivery system for delivering a medical device to a location within a patient's body |
WO2008098074A2 (en) * | 2007-02-06 | 2008-08-14 | Microcube, Llc | A delivery system for delivering a medical device to a location within a patient's body |
US8216217B2 (en) | 2007-08-23 | 2012-07-10 | Aegea Medical, Inc. | Uterine therapy device and method |
US8128592B2 (en) * | 2007-07-11 | 2012-03-06 | Apollo Endosurgery, Inc. | Methods and systems for performing submucosal medical procedures |
US20090082762A1 (en) * | 2007-09-20 | 2009-03-26 | Ormsby Theodore C | Radio frequency energy transmission device for the ablation of biological tissues |
US9023030B2 (en) | 2007-10-09 | 2015-05-05 | Boston Scientific Scimed, Inc. | Cooled ablation catheter devices and methods of use |
EP2211981A1 (en) * | 2007-10-09 | 2010-08-04 | Boston Scientific Limited | Electrophysiology electrodes and apparatus including the same |
US8322335B2 (en) | 2007-10-22 | 2012-12-04 | Uptake Medical Corp. | Determining patient-specific vapor treatment and delivery parameters |
US8147532B2 (en) | 2007-10-22 | 2012-04-03 | Uptake Medical Corp. | Determining patient-specific vapor treatment and delivery parameters |
WO2009086448A1 (en) | 2007-12-28 | 2009-07-09 | Salient Surgical Technologies, Inc. | Fluid-assisted electrosurgical devices, methods and systems |
US9924992B2 (en) | 2008-02-20 | 2018-03-27 | Tsunami Medtech, Llc | Medical system and method of use |
WO2009140359A2 (en) | 2008-05-13 | 2009-11-19 | Medtronic, Inc. | Tissue lesion evaluation |
US9050069B2 (en) | 2008-05-16 | 2015-06-09 | Medtronic Cryocath Lp | Thermocouple-controlled catheter cooling system |
US8133222B2 (en) * | 2008-05-28 | 2012-03-13 | Medwaves, Inc. | Tissue ablation apparatus and method using ultrasonic imaging |
US8721632B2 (en) | 2008-09-09 | 2014-05-13 | Tsunami Medtech, Llc | Methods for delivering energy into a target tissue of a body |
US8579888B2 (en) | 2008-06-17 | 2013-11-12 | Tsunami Medtech, Llc | Medical probes for the treatment of blood vessels |
US8679106B2 (en) * | 2008-07-01 | 2014-03-25 | Medwaves, Inc. | Angioplasty and tissue ablation apparatus and method |
US9700365B2 (en) | 2008-10-06 | 2017-07-11 | Santa Anna Tech Llc | Method and apparatus for the ablation of gastrointestinal tissue |
US9561066B2 (en) | 2008-10-06 | 2017-02-07 | Virender K. Sharma | Method and apparatus for tissue ablation |
US10064697B2 (en) | 2008-10-06 | 2018-09-04 | Santa Anna Tech Llc | Vapor based ablation system for treating various indications |
US9561068B2 (en) | 2008-10-06 | 2017-02-07 | Virender K. Sharma | Method and apparatus for tissue ablation |
US10695126B2 (en) | 2008-10-06 | 2020-06-30 | Santa Anna Tech Llc | Catheter with a double balloon structure to generate and apply a heated ablative zone to tissue |
US20100168717A1 (en) * | 2008-12-30 | 2010-07-01 | Grasse Martin M | Multi-lumen medical devices and methods of manufacturing same |
US9254168B2 (en) | 2009-02-02 | 2016-02-09 | Medtronic Advanced Energy Llc | Electro-thermotherapy of tissue using penetrating microelectrode array |
US11284931B2 (en) | 2009-02-03 | 2022-03-29 | Tsunami Medtech, Llc | Medical systems and methods for ablating and absorbing tissue |
JP5693471B2 (en) | 2009-02-11 | 2015-04-01 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Insulated ablation catheter device and use thereof |
JP5592409B2 (en) | 2009-02-23 | 2014-09-17 | サリエント・サージカル・テクノロジーズ・インコーポレーテッド | Fluid-assisted electrosurgical device and method of use thereof |
US20100286688A1 (en) * | 2009-05-08 | 2010-11-11 | Hughett Sr James David | Flexible ablation clamp |
US8414579B2 (en) | 2009-06-30 | 2013-04-09 | Boston Scientific Scimed, Inc. | Map and ablate open irrigated hybrid catheter |
JP2013503723A (en) | 2009-09-08 | 2013-02-04 | サリエント・サージカル・テクノロジーズ・インコーポレーテッド | Cartridge assembly for electrosurgical devices, electrosurgical units, and methods of use thereof |
US9775664B2 (en) | 2009-09-22 | 2017-10-03 | Mederi Therapeutics, Inc. | Systems and methods for treating tissue with radiofrequency energy |
US9474565B2 (en) | 2009-09-22 | 2016-10-25 | Mederi Therapeutics, Inc. | Systems and methods for treating tissue with radiofrequency energy |
US10386990B2 (en) | 2009-09-22 | 2019-08-20 | Mederi Rf, Llc | Systems and methods for treating tissue with radiofrequency energy |
WO2011037621A2 (en) | 2009-09-22 | 2011-03-31 | Mederi Therapeutics Inc. | Systems and methods for controlling use and operation of a family of different treatment devices |
US9750563B2 (en) | 2009-09-22 | 2017-09-05 | Mederi Therapeutics, Inc. | Systems and methods for treating tissue with radiofrequency energy |
US8696653B2 (en) | 2009-10-02 | 2014-04-15 | Cardiofocus, Inc. | Cardiac ablation system with pulsed aiming light |
WO2011044248A2 (en) | 2009-10-06 | 2011-04-14 | Cardiofocus, Inc. | Cardiac ablation image analysis system and process |
US11045221B2 (en) * | 2009-10-30 | 2021-06-29 | Medtronic, Inc. | Steerable percutaneous paddle stimulation lead |
US8900223B2 (en) | 2009-11-06 | 2014-12-02 | Tsunami Medtech, Llc | Tissue ablation systems and methods of use |
US9161801B2 (en) | 2009-12-30 | 2015-10-20 | Tsunami Medtech, Llc | Medical system and method of use |
US9445859B2 (en) | 2010-01-29 | 2016-09-20 | Medtronic Cryocath Lp | Multifunctional ablation device |
WO2011112991A1 (en) | 2010-03-11 | 2011-09-15 | Salient Surgical Technologies, Inc. | Bipolar electrosurgical cutter with position insensitive return electrode contact |
US20110295249A1 (en) * | 2010-05-28 | 2011-12-01 | Salient Surgical Technologies, Inc. | Fluid-Assisted Electrosurgical Devices, and Methods of Manufacture Thereof |
US9138289B2 (en) | 2010-06-28 | 2015-09-22 | Medtronic Advanced Energy Llc | Electrode sheath for electrosurgical device |
US8906012B2 (en) | 2010-06-30 | 2014-12-09 | Medtronic Advanced Energy Llc | Electrosurgical devices with wire electrode |
US8920417B2 (en) | 2010-06-30 | 2014-12-30 | Medtronic Advanced Energy Llc | Electrosurgical devices and methods of use thereof |
US9943353B2 (en) | 2013-03-15 | 2018-04-17 | Tsunami Medtech, Llc | Medical system and method of use |
WO2012052926A2 (en) | 2010-10-18 | 2012-04-26 | CardioSonic Ltd. | Tissue treatment |
US9566456B2 (en) * | 2010-10-18 | 2017-02-14 | CardioSonic Ltd. | Ultrasound transceiver and cooling thereof |
US9028417B2 (en) | 2010-10-18 | 2015-05-12 | CardioSonic Ltd. | Ultrasound emission element |
US8585601B2 (en) | 2010-10-18 | 2013-11-19 | CardioSonic Ltd. | Ultrasound transducer |
US9023040B2 (en) | 2010-10-26 | 2015-05-05 | Medtronic Advanced Energy Llc | Electrosurgical cutting devices |
WO2012064864A1 (en) | 2010-11-09 | 2012-05-18 | Aegea Medical Inc. | Positioning method and apparatus for delivering vapor to the uterus |
US8998893B2 (en) | 2010-12-07 | 2015-04-07 | Boaz Avitall | Catheter systems for cardiac arrhythmia ablation |
US11246653B2 (en) | 2010-12-07 | 2022-02-15 | Boaz Avitall | Catheter systems for cardiac arrhythmia ablation |
US9089340B2 (en) | 2010-12-30 | 2015-07-28 | Boston Scientific Scimed, Inc. | Ultrasound guided tissue ablation |
US9427281B2 (en) | 2011-03-11 | 2016-08-30 | Medtronic Advanced Energy Llc | Bronchoscope-compatible catheter provided with electrosurgical device |
ES2864589T3 (en) | 2011-04-12 | 2021-10-14 | Thermedical Inc | Devices for conformal therapy in fluid-enhanced ablation |
EP2713888B1 (en) | 2011-06-01 | 2019-09-04 | Boston Scientific Scimed, Inc. | Ablation probe with ultrasonic imaging capabilities |
CN103987336A (en) | 2011-09-14 | 2014-08-13 | 波士顿科学西美德公司 | Ablation device with multiple ablation modes |
US9125668B2 (en) | 2011-09-14 | 2015-09-08 | Boston Scientific Scimed Inc. | Ablation device with multiple ablation modes |
US9603659B2 (en) | 2011-09-14 | 2017-03-28 | Boston Scientific Scimed Inc. | Ablation device with ionically conductive balloon |
US9750565B2 (en) | 2011-09-30 | 2017-09-05 | Medtronic Advanced Energy Llc | Electrosurgical balloons |
US9662060B2 (en) | 2011-10-07 | 2017-05-30 | Aegea Medical Inc. | Integrity testing method and apparatus for delivering vapor to the uterus |
US8870864B2 (en) | 2011-10-28 | 2014-10-28 | Medtronic Advanced Energy Llc | Single instrument electrosurgery apparatus and its method of use |
US9314588B2 (en) | 2011-10-28 | 2016-04-19 | Medtronic Cryocath Lp | Systems and methods for variable injection flow |
EP2797536B1 (en) | 2011-12-28 | 2016-04-13 | Boston Scientific Scimed, Inc. | Ablation probe with ultrasonic imaging capability |
US10905494B2 (en) * | 2011-12-29 | 2021-02-02 | St. Jude Medical, Atrial Fibrillation Division, Inc | Flexible conductive polymer based conformable device and method to create linear endocardial lesions |
AU2013207994B2 (en) | 2012-01-10 | 2015-05-07 | Boston Scientific Scimed, Inc. | Electrophysiology system |
WO2013115941A1 (en) | 2012-01-31 | 2013-08-08 | Boston Scientific Scimed, Inc. | Ablation probe with fluid-based acoustic coupling for ultrasonic tissue imaging |
US9717554B2 (en) | 2012-03-26 | 2017-08-01 | Biosense Webster (Israel) Ltd. | Catheter with composite construction |
US8403927B1 (en) | 2012-04-05 | 2013-03-26 | William Bruce Shingleton | Vasectomy devices and methods |
US10357304B2 (en) | 2012-04-18 | 2019-07-23 | CardioSonic Ltd. | Tissue treatment |
US10639099B2 (en) | 2012-05-25 | 2020-05-05 | Biosense Webster (Israel), Ltd. | Catheter having a distal section with spring sections for biased deflection |
US11357447B2 (en) | 2012-05-31 | 2022-06-14 | Sonivie Ltd. | Method and/or apparatus for measuring renal denervation effectiveness |
EP3603501A1 (en) | 2012-08-09 | 2020-02-05 | University of Iowa Research Foundation | Catheter systems for surrounding a tissue structure |
US10022176B2 (en) | 2012-08-15 | 2018-07-17 | Thermedical, Inc. | Low profile fluid enhanced ablation therapy devices and methods |
WO2014047068A1 (en) | 2012-09-18 | 2014-03-27 | Boston Scientific Scimed, Inc. | Map and ablate closed-loop cooled ablation catheter |
US9211156B2 (en) | 2012-09-18 | 2015-12-15 | Boston Scientific Scimed, Inc. | Map and ablate closed-loop cooled ablation catheter with flat tip |
WO2014113724A2 (en) | 2013-01-17 | 2014-07-24 | Sharma Virender K | Method and apparatus for tissue ablation |
CN105188587A (en) | 2013-03-13 | 2015-12-23 | 波士顿科学医学有限公司 | Steerable ablation device with linear ionically conductive balloon |
US9610396B2 (en) | 2013-03-15 | 2017-04-04 | Thermedical, Inc. | Systems and methods for visualizing fluid enhanced ablation therapy |
US9033972B2 (en) | 2013-03-15 | 2015-05-19 | Thermedical, Inc. | Methods and devices for fluid enhanced microwave ablation therapy |
WO2014188430A2 (en) | 2013-05-23 | 2014-11-27 | CardioSonic Ltd. | Devices and methods for renal denervation and assessment thereof |
US9782211B2 (en) | 2013-10-01 | 2017-10-10 | Uptake Medical Technology Inc. | Preferential volume reduction of diseased segments of a heterogeneous lobe |
WO2015103574A1 (en) | 2014-01-06 | 2015-07-09 | Iowa Approach Inc. | Apparatus and methods for renal denervation ablation |
EP3137007A4 (en) | 2014-04-28 | 2017-09-27 | Cardiofocus, Inc. | System and method for visualizing tissue with an icg dye composition during ablation procedures |
EP4238521A3 (en) | 2014-05-07 | 2023-11-29 | Farapulse, Inc. | Methods and apparatus for selective tissue ablation |
US10179019B2 (en) | 2014-05-22 | 2019-01-15 | Aegea Medical Inc. | Integrity testing method and apparatus for delivering vapor to the uterus |
EP3145425A4 (en) | 2014-05-22 | 2018-02-14 | Aegea Medical, Inc. | Systems and methods for performing endometrial ablation |
WO2015192027A1 (en) | 2014-06-12 | 2015-12-17 | Iowa Approach Inc. | Method and apparatus for rapid and selective transurethral tissue ablation |
WO2015192018A1 (en) | 2014-06-12 | 2015-12-17 | Iowa Approach Inc. | Method and apparatus for rapid and selective tissue ablation with cooling |
US9974599B2 (en) | 2014-08-15 | 2018-05-22 | Medtronic Ps Medical, Inc. | Multipurpose electrosurgical device |
US10524684B2 (en) | 2014-10-13 | 2020-01-07 | Boston Scientific Scimed Inc | Tissue diagnosis and treatment using mini-electrodes |
EP3206613B1 (en) | 2014-10-14 | 2019-07-03 | Farapulse, Inc. | Apparatus for rapid and safe pulmonary vein cardiac ablation |
US10603105B2 (en) | 2014-10-24 | 2020-03-31 | Boston Scientific Scimed Inc | Medical devices with a flexible electrode assembly coupled to an ablation tip |
US10485604B2 (en) | 2014-12-02 | 2019-11-26 | Uptake Medical Technology Inc. | Vapor treatment of lung nodules and tumors |
EP3226744A4 (en) | 2014-12-03 | 2018-08-08 | Cardiofocus, Inc. | System and method for visual confirmation of pulmonary vein isolation during ablation procedures |
US9743854B2 (en) | 2014-12-18 | 2017-08-29 | Boston Scientific Scimed, Inc. | Real-time morphology analysis for lesion assessment |
US10531906B2 (en) | 2015-02-02 | 2020-01-14 | Uptake Medical Technology Inc. | Medical vapor generator |
US11389227B2 (en) | 2015-08-20 | 2022-07-19 | Medtronic Advanced Energy Llc | Electrosurgical device with multivariate control |
US11051875B2 (en) | 2015-08-24 | 2021-07-06 | Medtronic Advanced Energy Llc | Multipurpose electrosurgical device |
US10716612B2 (en) | 2015-12-18 | 2020-07-21 | Medtronic Advanced Energy Llc | Electrosurgical device with multiple monopolar electrode assembly |
US10130423B1 (en) | 2017-07-06 | 2018-11-20 | Farapulse, Inc. | Systems, devices, and methods for focal ablation |
EP3399934B1 (en) | 2016-01-05 | 2022-10-12 | Cardiofocus, Inc. | Ablation system with automated sweeping ablation energy element |
US10172673B2 (en) | 2016-01-05 | 2019-01-08 | Farapulse, Inc. | Systems devices, and methods for delivery of pulsed electric field ablative energy to endocardial tissue |
US10660702B2 (en) | 2016-01-05 | 2020-05-26 | Farapulse, Inc. | Systems, devices, and methods for focal ablation |
US20170189097A1 (en) | 2016-01-05 | 2017-07-06 | Iowa Approach Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
EP3416551B1 (en) | 2016-02-19 | 2022-10-12 | Aegea Medical Inc. | Apparatus for determining the integrity of a bodily cavity |
US11331140B2 (en) | 2016-05-19 | 2022-05-17 | Aqua Heart, Inc. | Heated vapor ablation systems and methods for treating cardiac conditions |
WO2017218734A1 (en) | 2016-06-16 | 2017-12-21 | Iowa Approach, Inc. | Systems, apparatuses, and methods for guide wire delivery |
US9743984B1 (en) | 2016-08-11 | 2017-08-29 | Thermedical, Inc. | Devices and methods for delivering fluid to tissue during ablation therapy |
JP7049326B2 (en) | 2016-10-04 | 2022-04-06 | アヴェント インコーポレイテッド | Cooled RF probe |
US20200094080A1 (en) | 2017-03-20 | 2020-03-26 | Sonivie Ltd. | Method for treating heart failure by improving ejection fraction of a patient |
USD851245S1 (en) | 2017-04-14 | 2019-06-11 | Cardiofocus, Inc. | Compliant balloon |
US9987081B1 (en) | 2017-04-27 | 2018-06-05 | Iowa Approach, Inc. | Systems, devices, and methods for signal generation |
US10617867B2 (en) | 2017-04-28 | 2020-04-14 | Farapulse, Inc. | Systems, devices, and methods for delivery of pulsed electric field ablative energy to esophageal tissue |
US11129673B2 (en) | 2017-05-05 | 2021-09-28 | Uptake Medical Technology Inc. | Extra-airway vapor ablation for treating airway constriction in patients with asthma and COPD |
US11344364B2 (en) | 2017-09-07 | 2022-05-31 | Uptake Medical Technology Inc. | Screening method for a target nerve to ablate for the treatment of inflammatory lung disease |
US11350988B2 (en) | 2017-09-11 | 2022-06-07 | Uptake Medical Technology Inc. | Bronchoscopic multimodality lung tumor treatment |
EP3681391A1 (en) | 2017-09-12 | 2020-07-22 | Farapulse, Inc. | Systems, apparatuses, and methods for ventricular focal ablation |
USD845467S1 (en) | 2017-09-17 | 2019-04-09 | Uptake Medical Technology Inc. | Hand-piece for medical ablation catheter |
US11419658B2 (en) | 2017-11-06 | 2022-08-23 | Uptake Medical Technology Inc. | Method for treating emphysema with condensable thermal vapor |
US11490946B2 (en) | 2017-12-13 | 2022-11-08 | Uptake Medical Technology Inc. | Vapor ablation handpiece |
US11389236B2 (en) | 2018-01-15 | 2022-07-19 | Cardiofocus, Inc. | Ablation system with automated ablation energy element |
US11083871B2 (en) | 2018-05-03 | 2021-08-10 | Thermedical, Inc. | Selectively deployable catheter ablation devices |
WO2019217317A1 (en) | 2018-05-07 | 2019-11-14 | Farapulse, Inc. | Systems, apparatuses, and methods for filtering high voltage noise induced by pulsed electric field ablation |
JP2021522903A (en) | 2018-05-07 | 2021-09-02 | ファラパルス,インコーポレイテッド | Systems, devices, and methods for delivering ablation energy to tissues |
CN116327352A (en) | 2018-05-07 | 2023-06-27 | 波士顿科学医学有限公司 | Epicardial ablation catheter |
WO2019232432A1 (en) | 2018-06-01 | 2019-12-05 | Santa Anna Tech Llc | Multi-stage vapor-based ablation treatment methods and vapor generation and delivery systems |
US11918277B2 (en) | 2018-07-16 | 2024-03-05 | Thermedical, Inc. | Inferred maximum temperature monitoring for irrigated ablation therapy |
JP2022501112A (en) | 2018-09-20 | 2022-01-06 | ファラパルス,インコーポレイテッド | Systems, devices, and methods for the delivery of pulsed field ablation energy to endocardial tissue |
US11653927B2 (en) | 2019-02-18 | 2023-05-23 | Uptake Medical Technology Inc. | Vapor ablation treatment of obstructive lung disease |
US10625080B1 (en) | 2019-09-17 | 2020-04-21 | Farapulse, Inc. | Systems, apparatuses, and methods for detecting ectopic electrocardiogram signals during pulsed electric field ablation |
US11471650B2 (en) | 2019-09-20 | 2022-10-18 | Biosense Webster (Israel) Ltd. | Mechanism for manipulating a puller wire |
US11497541B2 (en) | 2019-11-20 | 2022-11-15 | Boston Scientific Scimed, Inc. | Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses |
US11065047B2 (en) | 2019-11-20 | 2021-07-20 | Farapulse, Inc. | Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses |
US10842572B1 (en) | 2019-11-25 | 2020-11-24 | Farapulse, Inc. | Methods, systems, and apparatuses for tracking ablation devices and generating lesion lines |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1466248A (en) * | 1965-02-22 | 1967-01-20 | Intracavitary treatment instrument | |
DE3038885A1 (en) * | 1980-10-15 | 1982-05-27 | Dr. Eduard Fresenius, Chemisch-pharmazeutische Industrie KG Apparatebau KG, 6380 Bad Homburg | Electro-stimulation probe for e.g. pacemaker - has conductors as ducts contg. conductive liq. |
US4850351A (en) * | 1985-05-22 | 1989-07-25 | C. R. Bard, Inc. | Wire guided laser catheter |
WO1990007909A1 (en) * | 1989-01-18 | 1990-07-26 | Applied Urology, Inc. | Dilatation catheter assembly with cutting element |
EP0499491A2 (en) * | 1991-02-15 | 1992-08-19 | Cardiac Pathways Corporation | Endocardial mapping and ablation system and catheter probe and method |
EP0539125A1 (en) * | 1991-10-18 | 1993-04-28 | Ethicon, Inc. | Endoscopic tissue manipulator |
WO1994008519A1 (en) * | 1992-10-16 | 1994-04-28 | Shturman Cardiology Systems, Inc. | Device and method for directional rotational atherectomy |
US5368597A (en) * | 1993-05-24 | 1994-11-29 | Pagedas; Anthony | Reclosable pouch for laparoscopic use |
US5454370A (en) * | 1993-12-03 | 1995-10-03 | Avitall; Boaz | Mapping and ablation electrode configuration |
WO1995034346A1 (en) * | 1994-06-14 | 1995-12-21 | Scimed Life Systems, Inc. | Electrophysiology device |
US5487385A (en) * | 1993-12-03 | 1996-01-30 | Avitall; Boaz | Atrial mapping and ablation catheter system |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3044836A (en) * | 1955-05-20 | 1962-07-17 | Farmington Mfg Company | Structure using fluid for supporting a part thereof |
US5191883A (en) * | 1988-10-28 | 1993-03-09 | Prutech Research And Development Partnership Ii | Device for heating tissue in a patient's body |
FR2639238B1 (en) * | 1988-11-21 | 1991-02-22 | Technomed Int Sa | APPARATUS FOR SURGICAL TREATMENT OF TISSUES BY HYPERTHERMIA, PREFERABLY THE PROSTATE, COMPRISING MEANS OF THERMAL PROTECTION COMPRISING PREFERABLY RADIOREFLECTIVE SCREEN MEANS |
US4945912A (en) * | 1988-11-25 | 1990-08-07 | Sensor Electronics, Inc. | Catheter with radiofrequency heating applicator |
US5230349A (en) * | 1988-11-25 | 1993-07-27 | Sensor Electronics, Inc. | Electrical heating catheter |
US4979948A (en) * | 1989-04-13 | 1990-12-25 | Purdue Research Foundation | Method and apparatus for thermally destroying a layer of an organ |
DE3915636C1 (en) * | 1989-05-12 | 1990-04-26 | Sass, Wolfgang, Dr. | |
SU1690786A1 (en) * | 1989-06-30 | 1991-11-15 | Каунасский Медицинский Институт | Electrocardial electrode |
US5236413B1 (en) * | 1990-05-07 | 1996-06-18 | Andrew J Feiring | Method and apparatus for inducing the permeation of medication into internal tissue |
US5281213A (en) * | 1992-04-16 | 1994-01-25 | Implemed, Inc. | Catheter for ice mapping and ablation |
US5443470A (en) * | 1992-05-01 | 1995-08-22 | Vesta Medical, Inc. | Method and apparatus for endometrial ablation |
WO1994010924A1 (en) * | 1992-11-13 | 1994-05-26 | American Cardiac Ablation Co., Inc. | Fluid cooled electrosurgical probe |
DE4338758C2 (en) * | 1992-11-13 | 2001-08-09 | Scimed Life Systems Inc | Catheter assembly |
US5334193A (en) * | 1992-11-13 | 1994-08-02 | American Cardiac Ablation Co., Inc. | Fluid cooled ablation catheter |
US5342357A (en) * | 1992-11-13 | 1994-08-30 | American Cardiac Ablation Co., Inc. | Fluid cooled electrosurgical cauterization system |
US5348554A (en) * | 1992-12-01 | 1994-09-20 | Cardiac Pathways Corporation | Catheter for RF ablation with cooled electrode |
US5797903A (en) * | 1996-04-12 | 1998-08-25 | Ep Technologies, Inc. | Tissue heating and ablation systems and methods using porous electrode structures with electrically conductive surfaces |
US5462521A (en) * | 1993-12-21 | 1995-10-31 | Angeion Corporation | Fluid cooled and perfused tip for a catheter |
US5505730A (en) * | 1994-06-24 | 1996-04-09 | Stuart D. Edwards | Thin layer ablation apparatus |
US5681308A (en) * | 1994-06-24 | 1997-10-28 | Stuart D. Edwards | Ablation apparatus for cardiac chambers |
US5800482A (en) * | 1996-03-06 | 1998-09-01 | Cardiac Pathways Corporation | Apparatus and method for linear lesion ablation |
US5769880A (en) * | 1996-04-12 | 1998-06-23 | Novacept | Moisture transport system for contact electrocoagulation |
-
1996
- 1996-03-06 US US08/611,656 patent/US5800482A/en not_active Expired - Lifetime
- 1996-11-04 WO PCT/US1996/017536 patent/WO1997032525A1/en active IP Right Grant
- 1996-11-04 EP EP96937859A patent/EP0884978B1/en not_active Expired - Lifetime
- 1996-11-04 JP JP09531745A patent/JP2000506751A/en not_active Ceased
- 1996-11-04 DE DE69610566T patent/DE69610566T2/en not_active Expired - Fee Related
-
1998
- 1998-08-04 US US09/128,877 patent/US6119041A/en not_active Expired - Lifetime
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1466248A (en) * | 1965-02-22 | 1967-01-20 | Intracavitary treatment instrument | |
DE3038885A1 (en) * | 1980-10-15 | 1982-05-27 | Dr. Eduard Fresenius, Chemisch-pharmazeutische Industrie KG Apparatebau KG, 6380 Bad Homburg | Electro-stimulation probe for e.g. pacemaker - has conductors as ducts contg. conductive liq. |
US4850351A (en) * | 1985-05-22 | 1989-07-25 | C. R. Bard, Inc. | Wire guided laser catheter |
WO1990007909A1 (en) * | 1989-01-18 | 1990-07-26 | Applied Urology, Inc. | Dilatation catheter assembly with cutting element |
EP0499491A2 (en) * | 1991-02-15 | 1992-08-19 | Cardiac Pathways Corporation | Endocardial mapping and ablation system and catheter probe and method |
EP0539125A1 (en) * | 1991-10-18 | 1993-04-28 | Ethicon, Inc. | Endoscopic tissue manipulator |
WO1994008519A1 (en) * | 1992-10-16 | 1994-04-28 | Shturman Cardiology Systems, Inc. | Device and method for directional rotational atherectomy |
US5368597A (en) * | 1993-05-24 | 1994-11-29 | Pagedas; Anthony | Reclosable pouch for laparoscopic use |
US5454370A (en) * | 1993-12-03 | 1995-10-03 | Avitall; Boaz | Mapping and ablation electrode configuration |
US5487385A (en) * | 1993-12-03 | 1996-01-30 | Avitall; Boaz | Atrial mapping and ablation catheter system |
WO1995034346A1 (en) * | 1994-06-14 | 1995-12-21 | Scimed Life Systems, Inc. | Electrophysiology device |
Cited By (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6964660B2 (en) * | 1997-07-08 | 2005-11-15 | Atrionix, Inc. | Tissue ablation device assembly and method of electrically isolating a pulmonary vein ostium from an atrial wall |
WO1999048421A1 (en) * | 1998-03-27 | 1999-09-30 | Cardiac Pathways Corporation | Combination of linear ablation and cooled tip rf catheters |
US7276061B2 (en) | 1998-05-06 | 2007-10-02 | Atrionix, Inc. | Irrigated ablation device assembly |
WO1999056812A2 (en) * | 1998-05-06 | 1999-11-11 | Atrionix, Inc. | Irrigated ablation device assembly |
WO1999056812A3 (en) * | 1998-05-06 | 2000-07-20 | Atrionix Inc | Irrigated ablation device assembly |
US7959628B2 (en) | 1998-05-06 | 2011-06-14 | Atrionix, Inc. | Irrigated ablation device assembly |
US6522930B1 (en) | 1998-05-06 | 2003-02-18 | Atrionix, Inc. | Irrigated ablation device assembly |
US6527767B2 (en) | 1998-05-20 | 2003-03-04 | New England Medical Center | Cardiac ablation system and method for treatment of cardiac arrhythmias and transmyocardial revascularization |
US9055959B2 (en) | 1999-07-19 | 2015-06-16 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Methods and devices for ablation |
WO2002019934A1 (en) | 2000-09-08 | 2002-03-14 | Atrionx, Inc. | Medical device with sensor cooperating with expandable member |
US6475179B1 (en) | 2000-11-10 | 2002-11-05 | New England Medical Center | Tissue folding device for tissue ablation, and method thereof |
US7211055B2 (en) | 2002-01-15 | 2007-05-01 | The Regents Of The University Of California | System and method providing directional ultrasound therapy to skeletal joints |
US11052267B2 (en) | 2002-01-15 | 2021-07-06 | The Regents Of The University Of California | Back pain treatment using microwave sources |
US10603522B2 (en) | 2002-01-15 | 2020-03-31 | The Regents Of The University Of California | Method of treating back pain with microwave sources |
US10589131B2 (en) | 2002-01-15 | 2020-03-17 | The Regents Of The University Of California | Methods of delivering chemical denervation to the vertebral body |
US10272271B2 (en) | 2002-01-15 | 2019-04-30 | The Regents Of The University Of California | Method for providing directional therapy to skeletal joints |
US8915949B2 (en) | 2002-01-15 | 2014-12-23 | The Regents Of The University Of California | Method for providing directional therapy to skeletal joints |
US9770280B2 (en) | 2002-01-23 | 2017-09-26 | The Regents Of The University Of California | Implantable thermal treatment method and apparatus |
US8414509B2 (en) | 2002-01-23 | 2013-04-09 | The Regents Of The University Of California | Implantable thermal treatment method and apparatus |
US8864758B2 (en) | 2003-01-21 | 2014-10-21 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Catheter design that facilitates positioning at tissue to be diagnosed or treated |
US7247269B2 (en) | 2003-07-21 | 2007-07-24 | Biosense Webster, Inc. | Method for making a spiral array ultrasound transducer |
US7670335B2 (en) | 2003-07-21 | 2010-03-02 | Biosense Webster, Inc. | Ablation device with spiral array ultrasound transducer |
US7655005B2 (en) | 2003-12-31 | 2010-02-02 | Biosense Webster, Inc. | Circumferential ablation device assembly with dual expandable members |
US8486063B2 (en) | 2004-10-14 | 2013-07-16 | Medtronic Ablation Frontiers Llc | Ablation catheter |
US9642675B2 (en) | 2004-10-14 | 2017-05-09 | Medtronic Ablation Frontiers Llc | Ablation catheter |
US8617152B2 (en) | 2004-11-15 | 2013-12-31 | Medtronic Ablation Frontiers Llc | Ablation system with feedback |
US9005194B2 (en) | 2004-11-24 | 2015-04-14 | Medtronic Ablation Frontiers Llc | Atrial ablation catheter adapted for treatment of septal wall arrhythmogenic foci and method of use |
US8273084B2 (en) | 2004-11-24 | 2012-09-25 | Medtronic Ablation Frontiers Llc | Atrial ablation catheter and method of use |
US8932208B2 (en) | 2005-05-26 | 2015-01-13 | Maquet Cardiovascular Llc | Apparatus and methods for performing minimally-invasive surgical procedures |
US9468495B2 (en) | 2005-06-20 | 2016-10-18 | Medtronic Ablation Frontiers Llc | Ablation catheter |
US7850685B2 (en) | 2005-06-20 | 2010-12-14 | Medtronic Ablation Frontiers Llc | Ablation catheter |
US8337492B2 (en) | 2005-06-20 | 2012-12-25 | Medtronic Ablation Frontiers Llc | Ablation catheter |
US8979841B2 (en) | 2005-06-20 | 2015-03-17 | Medtronic Ablation Frontiers Llc | Ablation catheter |
US8771267B2 (en) | 2005-06-20 | 2014-07-08 | Medtronic Ablation Frontiers Llc | Ablation catheter |
US8834461B2 (en) | 2005-07-11 | 2014-09-16 | Medtronic Ablation Frontiers Llc | Low power tissue ablation system |
US9566113B2 (en) | 2005-07-11 | 2017-02-14 | Medtronic Ablation Frontiers Llc | Low power tissue ablation system |
WO2007019876A1 (en) | 2005-08-19 | 2007-02-22 | De Neve Werner Francois | Device and method for assisting heat ablation treatment of the heart |
US8657814B2 (en) | 2005-08-22 | 2014-02-25 | Medtronic Ablation Frontiers Llc | User interface for tissue ablation system |
US9265563B2 (en) | 2006-02-22 | 2016-02-23 | Custom Medical Applications, Inc. | Ablation instruments and related methods |
US8728073B2 (en) | 2006-10-10 | 2014-05-20 | Biosense Webster, Inc. | Multi-region staged inflation balloon |
US8771269B2 (en) | 2007-05-11 | 2014-07-08 | Medtronic Ablation Frontiers Llc | RF energy delivery system and method |
US10219857B2 (en) | 2007-05-11 | 2019-03-05 | Medtronic Ablation Frontiers Llc | RF energy delivery system |
US8641704B2 (en) | 2007-05-11 | 2014-02-04 | Medtronic Ablation Frontiers Llc | Ablation therapy system and method for treating continuous atrial fibrillation |
US10058380B2 (en) | 2007-10-05 | 2018-08-28 | Maquet Cordiovascular Llc | Devices and methods for minimally-invasive surgical procedures |
US10993766B2 (en) | 2007-10-05 | 2021-05-04 | Maquet Cardiovascular Llc | Devices and methods for minimally-invasive surgical procedures |
EP2881057A1 (en) | 2013-12-05 | 2015-06-10 | Region Nordjylland | Apparatus for creating linear lesions in body tissue within a body vessel |
Also Published As
Publication number | Publication date |
---|---|
US5800482A (en) | 1998-09-01 |
US6119041A (en) | 2000-09-12 |
EP0884978B1 (en) | 2000-10-04 |
EP0884978A1 (en) | 1998-12-23 |
DE69610566D1 (en) | 2000-11-09 |
DE69610566T2 (en) | 2001-06-28 |
JP2000506751A (en) | 2000-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5800482A (en) | Apparatus and method for linear lesion ablation | |
US5895417A (en) | Deflectable loop design for a linear lesion ablation apparatus | |
US6032077A (en) | Ablation catheter with electrical coupling via foam drenched with a conductive fluid | |
US5882346A (en) | Shapable catheter using exchangeable core and method of use | |
US6010500A (en) | Telescoping apparatus and method for linear lesion ablation | |
US6917834B2 (en) | Devices and methods for creating lesions in endocardial and surrounding tissue to isolate focal arrhythmia substrates | |
US7081115B2 (en) | Probes having helical and loop shaped inflatable therapeutic elements | |
CA2282488C (en) | Over-the-wire ep catheter | |
EP1663044B1 (en) | Probe assembly for creating circumferential lesions within a vessel ostium | |
CA2251041C (en) | Linear ablation device and assembly | |
US6908464B2 (en) | Loop structures for supporting diagnostic and therapeutic elements in contact with body tissue and expandable push devices for use with same | |
US7063682B1 (en) | Catheter distal assembly with pull wires | |
US6203525B1 (en) | Catheterdistal assembly with pull wires | |
US7104990B2 (en) | Loop structure including inflatable therapeutic device | |
US6048329A (en) | Catheter distal assembly with pull wires | |
US6120499A (en) | Intravascular RF occlusion catheter | |
JP2007175521A (en) | Linear ablation device and assembly | |
CA2221681A1 (en) | Over-the-wire ep catheter | |
WO1998038912A9 (en) | Over-the-wire ep catheter | |
WO2002045608A9 (en) | Ablation catheter assembly and method for isolating a pulmonary vein | |
WO2004100813A2 (en) | Multi-purpose catheter apparatus and method of use | |
JP2002501769A (en) | Catheter distal assembly with pull wire |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1996937859 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1996937859 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 1996937859 Country of ref document: EP |